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Bovine heart mitochondrial succinate.:.ubiquinone (Q) reductase (SQR), also known 
as Complex II, catalyzes.oxidation of succinate to fumarate in the citric acid cycle·and 
transfers electrons to ubiquinone in the mitochondrial respiratory chain. The other 
components of the respiratory chain are NADH-ubiquinone reductase (NQR, Complex I), 
Ubiquinol-cytochrome c reductase (QCR, Complex III) and cytochrome c oxidase (CcO, 
Complex IV) (Figure 1). Succinate and NADH which are produced in the citric acid cycle, 
are oxidized to fumarate and NAD+ by donating electrons to ubiquinone via SQR and NQR, 
respectively. The electrons are then transferred to cytochrome c by QCR. Cytochrome c 
is oxidized when it donates electrons to molecular oxygen by CcO. Electrons transferred 
. through NQR, QCR, and CcO, are accompanied with the translocation of protons across 
the inner mitochondrial membrane to generate a proton gradient for ATP synthesis ( 1, 2). 
Although the electron transfer catalyzed by SQR does not generate proton gradient for ATP 
synthesis, study of SQR is nevertheless important because of its unique position in cellular 
metabolism in bridging the TCA cycle and the electron transport chain. 
Bovine SQR was first isolated from bovine heart mitochondria by Ziegler and Doeg 
in 1962 (3). However, this isolation procedure was not ideal; the yield was poor and 
purification complicated by the use of organic solvent fractionation. A simpler and more 
reliable method to prepare active and pure enzyme complex was introduced by our group in 
1982 (4). This method involves the treatmentof SCR with Triton X-100 followed by 
calcium phosphate column chromatography at different pH's. 








Figure 1. Electron and Proton Transfer Paths in the Mitochondrial Respiratory Chain. 
(Modified from references 9 and 53) 
2 
3 
Purified SQR has five subunits with apparent molecular weights of 70, 28, 14, 11, 
and 9 kDa as estimated by high resolution SOS-PAGE. The active. complex is associated· 
with six prosthetic groups, namely, a covalently linked FAD, three Fe-S clusters, 
cytochrome b heme, and ubiquinone (Figure 2). . 
Mitochondrial SQR can be resolved into two reconstitutively active fractions: a 
soluble SDH and a membrane anchoring fraction. The soluble SDH which has been 
purified and characterized by different groups ofresearchers (5 - 7) is made up of the larger· 
two polypeptides, namely 70 kDa flavoprotein (FP) and 27 kDa iron sulfur protein (IP). 
. . . . 
Purified SDH possesses two types of enzyme activities: 1. redox dye activity, which. 
represents its ability to transfer electrons from succinate to artificial electron acceptors, such . 
as phenazinemethosulfate and ferricyanide; · and 2. reconstitutive activity which is its ability 
to reconstitute with QPs to form SQR. The SDHofbovine SQR has sequence homology 
. . . ' . . . . . 
to SDHs from Escherischia coli SQR, Bacillus subtilis SQR and fumarate dehydrogeriase 
-· of E. coli quinol-:- fumarate reducta,se (QFR) (8,9). (QFRs belong to a class of enzymes 
that catalyze the transfer of electro~s during anaerobiosis from inenaquinol in E. coli and 
rhodoquinol in Ascaris suum to the terminal acceptor fumarate.) 
The FP subunit of SDH lodges the dicarboxylate binding site. Bovine FP cDNA 
has been cloned and sequenced (10). The amino acid sequences from different species 
show several conserved regions a-j (Figure 3). Segment b of the FP polypeptide contains 
the histidine residue to which FAD is covalently bound via N(3)-Scx"'"riboflavin linkage 
(11). Segments a, h, .and i are probably in contact with the AMP part of FAD (12). FAD 
. .. . 
is covalently bound to FP before enzyme assembly (13). It has been reported in yeast that 
. . . . ·. . 
FP had to be processed by a m~trix processing peptidase befpre the covalent attachment of 
FAD (14, 15). 
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Figure 2. Structures of the Prosthetic Groups in Succinate-Q Reductase. 
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Figure 3. Comparison of Flavoprotein peptide sequences. (Accession #s : 
Bovine, P31039; A. suum, D30650; E. coli SQR, P10444; E. coli 
QPR, P00363) (adapted from 57) 
· The purpose of the covalent bond is to modulate the electronic properties of the flavin 
sufficiently to enable the enzyme to function as a succino~oxidase. Mutagenesis studies of 
E.coli QFR proved that succinate oxidation is possible·only when FAD is covalently 
bound to FP (16). 
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FAD is a two electron carrier. The midpoint potentials (Em) of the two consecutive 
electron transfer steps of PAD inbovine SQRweredeterminedto be :-127 mV and-31 mV 
at pH 7, corresponding to the midpoint potential of-79 mV fotthe overallreaction (17). 
The SDH flavin radical state (stability constant= 2.5 x 10:2 (17)) is a far more stable redox 
intermediate compared to the othertypical n=2 components, such as NAD+/NADH or 
Q/QH2 in a hydrophobic environment (18r 
The IP subunit.of SDH harbors the three iron-sulfur clusters, [2Fe-2S]<2+,i+>, [4Fe-
4S]<2+,I+>, [3Fe-4S]{l+,o>, called S-1, S-2, S-3 in SQRand FR-1, FR-2, and FR-3 in QPR, 
respectively. Table 1. shows the different therinodynamic parameters of iron sulfur clusters 
from bovine SQR, E. coli SQR, E. coli QPR, and B. subtilis SQR (19). It is inferred 
that the Em of S-3 in SQRs from different organisms is influenced by the type of quinone. 
associated with the enzyme (20). In SQRs that use ubiquinone, S-3 has a higher Em value 
than enzymes which use menaquinone (21 }. The .amino acid sequence of IP of beef heart 
. . . ,. . ' 
SDH is available from peptide .sequencing (22). Amino acid sequerice comparison of IPs 
from different organisms show a well conserved N'-terminal domain with the motif· 
CxxxxCxxC ......... C ligating S-1, re~embling a plant type ferredoxin and a C-terminal 
domain with motifs CxxCxxCxxxCP and CxxxxxCxxxCP resembling bacterial ferredo:xins 
ligating S-2 and S-3. The Em of S-1 is high compared to that of [2Fe-2S] centers of plant 
ferredoxins. Mutagenesis studies of E.coli QPR confirm that S-1 is·ligated by 3 cysteines 
and a water molecule, the latter being hydrogen bonded to an aspartate or cysteine. 
Information about the spatial organization of theiron-sulfur centersis also available from 
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Table I. 
Midpoint Potentials of the Iron Sulfur Clusters of Complex II 
Enzyme Quinone. [2Fe-2S] 4Fe-4S] .. [3Fe-4S] 
·(Acceptor 
/Donor) . (mV) 
BovineSQR Ubiquinone 0 -260 +60 to +120 
E.coli SQR Ubiquinone +10 -175 +65 
E.coli QFR Menaquinone -20 to -79 -320 -50 to -70 

















Figure 4. Proposed Topological Model of Succinate-Q Reductase 
(Adapted from references 9 and 54) 
the epr-detectable magnetic spin-spin interactions. The distance between FAD and S-1 is 
12-18 A, S-1 and S-2 is 9-12 A, and S-1 and S-3 is 10-20 A. Strong spin-spin coupling 
between S-2 and S-3 has also been detected, indicating close mutual distance of these two 
clusters (9). 
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The [3Fe-4S] cluster (S.:.3) of SDH has an important structural role, demonstrated 
by reconstitution studies of bovine SQR. Purified soluble SDH coµld be reconstituted with 
QPs to form SQR only if S-3 was intact (23-25). It was also observed that extraction of 
ubiquinone from submitochondrial particles affected the redox midpoint potential of S-3 
(26). 2-Thenoyltrifluoroacetone (TTFA) is a specific inhibitor of SQR and inhibits electron 
transfer between S-3 and quinone in mammalian mitochondrial SQR(8). Addition of 
TTFA increases the.signal amplitude of S-3 and shifts the midpoint potential in both pigeon· 
heart (27) and beef heart (28) submitochondrial particles. An interesting mutation P159Q 
in the FR-3 ligation motifin E.coli QFR (29) produced a mutant enzyme that was 
inactivated by the substrate succinate in the presence of quinone. Based on this finding it 
has been proposed that the FR-3 is located in the vicinity of quinone binding region of E. 
coli QFR (29). 
The function of the hydrophobic subunits of SQR is to provide membrane docking 
for SDH and Q-binding domains in the complex. The nomenclature "QPs" hails from our 
laboratory indicating the proteins responsible for Q-binding in SQR Similar proteins in 
NQR and QCR are called QPnand QPc respectively. ·The number of subunits comprising 
the QPs fraction could be one (SDHC in B. subtilis, and Wolinella succinogenes), two 
(SDHC & SDHD, in E. coli; SDH3 & SDH4 in Saccharomyces cerevisiae and 
Paracoccus denitrificans), or three (QPsl, QPs2, QPs3, in bovine heart). Table II shows a 
comparison of the membrane anchors from different species. 
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Table II 
Membrane Anchors in Succinate-Q Reductases From Different Species 
Name of speci~ .~ · No. of No. of Properties of 
.. -
anchor hemes cytochrome 
polypeptides a-band[nm] 
Em(mV) EPR signals 
Bovine SQR 3 1 -185 3.46 560 
E.coli SQR 2 1 +36 3.63 556 
B. subtilis SQR .1 2 b8 +65, 3.68 558 
bL-95 3.42 
W. succinogenes QFR 1 2 b8 -20, 560 
bL -200 
A. suum (adult) QFR 2 1 -34 3.6 558 
P. denitrificans SQR 2 1 -175 557 
E.coli QFR 2 0 
S. cerevisiae SQR 2 0 
The membrane docking function of QPs is evidenced by chemical modification 
studies of QPs that indicated one histidine and two carboxyl groups in the QPs fraction to 
be essential for interaction with SDH in the formation an active SQR (30, 31). 
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The involvement of QPs in the Q-binding of bovine SQR is shown by the detection 
of ubisemiquinone radicals in intact and reconstituted SQR in the presence of excess added 
quinone (5: 1 molar ratio to flavin) (32). No Q-radical was detected in SDH after the 
addition of Q. The Q-radical in bovine SQR showed a rapidly relaxing g=2.00 
semiquinone .signal at 150 K as well as split signals arising from spin-spin interactions 
between two semiquinones at 10 K (32, 33). From the modeling of the dipolar coupling 
using a point charge approximation, the distance between the two semiquinones was 
estimated to be 7.7 A (33). Oriented multilayers of bovine heart mitochondrial membranes 
were used to show that the semiquinone pair was ordered with quinone-quinone dipolar 
axis perpendicular to the membrane, in a transmembrane fashion (34). The· 
ubisemiquinone radicals detected in intact or reconstituted SQR do not show power 
saturation even at 200 mW, and differ from the antimycin sensitive radicals detected in 
QCR that show power saturation at 1 mW (32). The structural requirements for the Q-
binding site in bovine SQR differ from those in QCR (35, 36). When a Q analog is used as 
electron donor for QCR, a 10 carbon side chain is required for maximum activity, whereas 
only a 5-carbon side-chain is necessary for a Q-analog to serve as electron acceptor for 
SQR (36). The structural requirements for quinone derivatives to be reduced by SQR are 
more specific than for quinol derivatives to be oxidized by QCR (Table III). When Q 
derivatives are used as the electron acceptor for SQR, the methyl group at the 5-position is 
less important than the methoxy groups at the 2- and 3- positions. Replacing the 5-methyl 
group with hydrogen causes a slight increase in activity. However, replacing one or both 
of the 2- and 3- methoxy groups with a methyl group completely abolishes electron 
acceptor activity. Replacing the 3-methoxy group with hydrogen results in a complete loss 
of electron-acceptor activity, while replacing the 2-methoxy with hydrogen results in an 
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Table III. 
Comparison of Electron-Transfer Activity of Q-derivatives (36) 
Q derivatives R2 R3 RS Activities (%) 
As acceptor As donor 
forSQR forQCR 
QOClO MeO MeO Me 100 100 
2-Me-Q0C 10 Me MeO Me 0 15 
3-Me-Q0C 10 MeO Me Me 0 14 
5-Me-PQ0C 10 Me Me Me 0 20 
2-H-QOClO. H MeO Me 29 54 
3-H-QOClO MeO H Me 0 27 
2-H-5-Me-PQ0C10 H Me Me 32 22 
3-H-5-Me-PQ0C10 Me H Me 0 20 
5-H-'QoC10 MeO MeO H 117 91 
2-Me-5-H-Q0C10 Me MeO H 18 25 
3-Me-5-H-Q0C 10 MeO Me H 9 23 
PQ0C10 Me Me H 0 27 
3,5~Di-H-Q0C10 MeO H H 0 6 
2,5-Di-H-QOClO H MeO H 30 11 
5-Me0-PQ0C10 Me Me MeO 0 20 
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activity decrease of 70%, suggesting that the 3-methoxy group is more critical than the 
methoxy group at the 2-position. On the other hand all the 1,4-benzoquinol derivatives 
showed partial activity when used as electron donors for QCR. The plastoquinone 
derivatives which show no electron acceptor activity for SQR, are reducible by succinate in 
the presence of SCR.. This reduction is antimycin sensitive and requires endogenous Q, 
suggesting that the plastoquinone derivatives can only accept electrons from the 
ubisemiquinone radical at the Qi site of QCR and cannot accept electrons from QPs of SQR 
(36). 
In order to understand the quinone-proteininteraction, ids essential to identify the 
putative Q-binding sites. The presence of two quinone binding sites in E. coli QFR has 
been suggested by mutagenesis studies (37) and by inhibitor kinetic analyses of putative Q-
binding site mutants (38). Inhibitor binding studies on bovine SQR also suggesttwo Q-
binding sites (38) in the complex. When a succinate-free, Q-deficient SQR from bovine 
heart was treated with a [3H]-azido-Q derivative, (3-azido-2-metbyl.:.5-methoxy-6-(3,7-
dimethyl-octyl)-l,4-benzoquinone), in the dark followed by illumination with a long 
wavelength UV radiation, about 50% of bound Q was located on QPs 1 subunit and other 
50% was equally distributed in QPs2 and QPs3. No radioactivity was found in the SDH 
subunits indicating thatQPs subunits are responsible for Q-binding (39).(Figure 5). The 
lower azido-Q uptake by QPs2 and QPs3 may result from portions of the Q-binding sites 
being contributed by these two subunits or from the preferential occupation of these two 
subunits by the endogenous Q present in the partially Q-deficient SQR. 
In order to identify the Q-binding domain in these Q-binding subunits, knowledge 
of their amino acid sequence is essential. The cDNA information for QPsl was obtained 
by our group by immunological screening procedures ( 40) and the Q-binding domain in 
QPsl,was identified by isolating and sequencing of an azido-Q-linked peptide as the stretch 
connecting transmembrane helices 2 and 3 that protrudes from the surface on the matrix 
14 
PP IP QPsl 23 
Figure 5. Distribution of [3H]-azido-Q Label Among the Subunits of SQR (39) 
side of the inner membrane (39). The availability of sequence information of QPs2 and 
QPs3 is required for the elucidation ofQ-binding domain(s) in these two subunits. 
Another interesting aspect among the anchor subunits is the association of heme b 
(2 hemes in B. subtilis SQR and Wolinella succinogenes QPR, 1 heme in E. coli SQR, 
A. suum QPR, Bovine SQR and no heme in E. coli QPR) (Table II). EPR and near 
infrared MCD spectroscopic studies suggested bis-histidine axial ligation of cytochrome 
b560 in bovine SQR (41), E.coli SQR (42), B. subtilis SQR (43). The histidines 
important for heme ligation have been identified in B. subtilis SQR (44) .and E.coli SQR 
(45). 
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The involvement of cytochrome b560 in SQR catalysis has been controversial. Since 
cytochrome b560 in bovineSQR is sub-stoichiometric to FAD and is not reducible by 
succinate, direct participation of cytochrome b560 in the catalytic function of SQR is not 
likely. Alternatively, it has been proposed that cytochrome b560 functions as a mediator 
between low potential Fl/F and Q/Q couples in a dual pathway model of electron flow 
(Figure 6) through cardiac complex II (46, 47). It is also suggested that cytochrome b560 is 
necessary for the binding and simultaneous stabilization of two semiquinones ( 48). 
In spite of the rather unclear role of this cytochrome b560 in catalysis there is 
considerable evidence for its structural role in bovine SQR. The differences observed in 
the properties of this cytochrome in isolated QPs and in native or reconstituted SQR are 
listed as follows: (1) the dithionite reduced form of cytochrome b560 in QPs fraction has a 
symmetrical a-absorption peak, which upon reconstitution with SDH becomes broadened 
showing a shoulder at 553nm identical to the absorption spectrum of cytochrome b560 in 
SQR. (2) the dithionitereduced form of cytochrome b560 in isolated QPs is reactive to 
carbon monoxide whilethat in SQR is nonreactive. Addition of SDH to QPs converts 
cytochrome b560 from CO reactive to CO nonreactive. (3) The redox potential of 
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Figure 6. Dual Pathway Model of Electron Transfer Through Succinate-Q Reductase 
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(-185 m V). Upon addition of SDH the redox potential of about 46% of the cytochrome 
b560 in QPsbecomes identical to that in SQR. (4) cytochrome b560 in QPs shows two EPR 
signals, g=3.07,.and g=2.91, the former disappears when QPs is reconstituted with SDH 
and a signal at 3.46 appears corresponding to that in SQR. In addition to this structural 
role this cytochrome b560 inay also serve as a low potential electron entrance for fumarate 
reduction under anaerobic conditions (49). 
The cytochrome b556 in E. coli SQR has been recently characterized (50) and is 
different from the bovine cytochrome b560• In E.coli SQR, the cytochrome b556 has 
identical absorption properties in purified membrane anchor fraction as well as in isolated 
and reconstituted SQR. The dithionite reduced cytochrome b556 shows a symmetrical ex-
peak and is CO insensitive in the presence or absence of SDH. This suggests that the heme 
environment in the E. coli and bovine enzymes is.not identical. 
Very recently great progress has been made in our laboratory in the expression of 
mitochondrial QPsl in E.coli as a GST-Fusion protein. Recombinant GST-QPsl was 
isolated in a soluble form and reconstituted with hemin chloride in vitro · to obtain all the 
properties of cytochrome b560 of QPs except the reconstitution with SDH (51). This work 
strongly indicates that cytochrome b560 in mitochondrial QPs is solely contributed by QPsl. 
This finding is contrary to that by Nakamura et al in their gene deletion studies of E.coli 
SQR that both subunits are necessary for the formation of cytochrome b556 (52). This 
report provides us the incentive to investigate whether the smaller QPs subunits can also 
provide histidine ligands for cytochrome b560 in SQR. 
The structure-function study of SQR requires the knowledge of Q-binding and 
cytochrome b ligation of QPs2 and QPs3 and thus the need for amino acid sequence of 
QPs2 and QPs3. In this thesis I report the cloning of QPs3 cDNA, expression of QPs3 as 
a GST fusion protein in E. coli cells,· isolation and characterization of recombinant QPs3. 
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CHAPTER I 
ISOLATION OF THE cDNA ENCODING QPs3 FROM A BOVINE 
HEART cDNA LIBJlARY · 
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Structure-function studi~s of SQR requires the knowledge of amino acid sequences 
of all the membrane anchor subunits. While the largest QPs subunit has been cloned and 
sequenced (1) and its participatiqn in Q-binding established (2) the involvement of QPs2 
and QPs3 in Q-binding is rather uncertain. When a Q-deficient, succinate-free SQR was 
photoaffinity labeled with azido-Q derivatives, some radioactivity was found in QPs2 and 
QPs3. Although the radiolab~l of QPs2 and QPs3 was 45% and 50% of what was found 
in QPs 1, Q-binding function of these two smaller subunits cannot be ruled out. The 
identification of Q-binding domains in QPs2 and QPs3 requires knowledge of the amino 
acid sequences of both subunits. There are two ways to obtain amino acid sequence 
information. One is by peptide sequencing. This method is rather impractical and time 
consunring for our purpose. A better approach is to .obtain the cDNA of QPs3 ;md deduce 
the peptide sequence from nucleotide sequence. The second method is more attractive since 
our group has reported several cONA clones of pritochondrial membrane proteins and we 
have the expertise to do this in our lab. In this chapter, I report the cloning and sequencing. 
of QPs3 cDNA clone from a bovine heart cDNA library. 
Experimental Procedures 
Materials 
Acrylamide, sodium dodecyl sulfate, urea, glycine, bovine serum albumin, Triton 
X-100, sodium cholate, DCPIP,and ~-mercaptoethanol were obtained from Sigma. 
Phenyl sepharose CLAB was from Pharmacia. Calcium phosphate was prepared 
according to Jenner (3), and mixed at a ratio of 3: 1 with cellulose powder prior to use in 
column chromatography. 
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Restriction enzymes were either from Promega or Life Technologies Inc. Taq DNA 
polymerase, T4 DNA Polymerase, Erase-a-base systernwere fromPromega. 
Chymotrypsin, Trypsin, DTT, DNAse I, RNAse A, IPTG, X'."gal,.gelatin, BCIP, and 
. . 
NBT were from Sigma. Nitrocellulose and nylon membranes were from Schleicher and 
Schuell. Protein A Horseradish :peroxidase conjugate, Goat anti-rabbit IgG-.alkaline 
phosphatase conjugate, SDS-:P AGE standards were from Biorad. TA Cloning kit was 
from Invitrogen .. Primers for PCR and Oligonucleotide probes were synthesized at the 
Recombinant DNA/Protein Resource Facility at Oklahoma State University. Bovine heart 
cDNA expression libraries constructed with 1'.gtl l vector and A.ZAP vector were purchased 
from Clontech andStratagene respectively. Nonradioactive labeling system was from Life 
Technlogies Inc. Chemiluminiscent substrate, Lumiphos 530 for streptavidin alkaline 
phosphatase was from BoehrringerMapneheim. 
BacteriaI··strains. Phages.and Plasmids. 
E.coli strains use.d were as follows:~ Yl090r"[L1lacU169L1(lon, araD)139 
strAsupF(trpC:TnlO)J was used as host for plaque screening and propagation of 1'.gtl 1 
recombinants. INVaF' -F' end.Al recAJ hsdR17 (rk-, m/) supE44 thi-1 gyrA96 relAJ 
</)80lacZL1Ml5 L1(lacZYA-argF)U169;,.- was used as a host for PCR2.1 vector propagation. 
XLl-Blue MRF·- L1 (mcrA) 183, L1(mcrCB-hsdSMR-mrr) 173, endAJ, supE44, thi-1, 
recAJ, gyrA96, relAJ, lac/F' proAB, lacflL1Zm15, TnlO (tef)] was used as host for plaque 
screening and propagation of 1'. Uni-ZAP XR recombinants. 
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Molecular Cloning and DNA Sequencing 
All cloning procedures including isolation and purification of lambda phage DNA 
were performed according to the methods in Sambrook et. al (4). DNA sequencing by the 
dideoxy method of Sanger was done with a Sequenase™ 2.0 kit from Life Technologies 
· Inc. Automated DNA sequencing was performed at the Recombinant DNA/Protein 
Resource Facility at Oklahoma State University. Full length cDNA was sequenced either 
. . . . 
by subcloning of smaller overlapping fragments or by primer waJJcing. 
Isolation of Pure QPs3 Protein 
Submitochondrial particles (5), SCR (6), and SQR (7) were prepared according to 
previously reported procedures. SQR from the second calcium phosphate-cellulose column 
. . . ' 
was concentrated to a protein concentration of 4 mg/ml by membrane filtration ( centriprep-
30, Amicon). Alternately, SQR was precipitated by 43% ammonium sulfate saturation, 
centrifugation at 48,000 x g for 20 min and dissolved in 50mM phosphate buffer pH 7 .8, 
containing 0.2% sodium cholate and 10% glycerol. 
SQR was assayed for its ability to catalyze Q reduction or Q-stimulated DCPIP 
reduction by succinate. The assays were performed at room temperature in a Shimadzu 
UV.,.21Q1PC. The reaction mixture used forQ-stimulated DCPIP reduction assay contains 
38µmol of DCPIP, 100 µmol of sodium/potassium phosphate buffer, pH 7.4, 20 µmol of 
succinate, 10 nmol of EDTA, 25 nmol of Q0C10 and 0.01 % Triton X-1 OOin the total 
vol~me of l ml. The reduction of DCPIP was followed by measuring the absorption . 
decrease at 600 nm, using a milliinolar extinction coefficient of 21 mM·1cm·1 
QPs was prepared from SQR by Sepharose CL-4B column chromatography with 
different concentrations of detergents~ Succinate-Q reductase was diluted to 2 mg/ml with 
50 mM Tris-HCl, pH 7.4, containing 0.2% sodium cholate. The solution was stirred at 
room temperature for 30 min and applied to a phenyl-sepharose CL-4B column equilibrated 
with 50 mM Tris-HCl pH 7.4, containing 0.2% sodium cholate. The column was 
successively washed with 50 mM Tris-HCl pH7.4, containing 2% sodium cholate, 50 mM 
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Tris-HCl pH 7.4, containing 2% sodium cholate and 4 M urea followed by the initial buffer 
to wash outthe remaining urea. QPs was eluted from the column with 50 mM Tris-HCl 
pH 7.4, containing 0.15% SOS. 
Pure QPs3 protein was isolated from the QPs fraction by preparative SOS-PAGE 
using high resolution gel system of Schagger et al (8) except that 8M urea was used in the 
separating gels instead of glycerol. The separating gels were allowed to polymerize for at 
least4 hours. The crude QPs, 1.5 mg/mL, was digested with 1 %SOS and 1 % ~-
mercaptoethanol and incubated at 37 QC for 5 hours. The digested sample was loaded on a 
gel slab in two strips sandwiched with three reference wells ( one on each side and one at 
the center) loaded with the digested samples treated with fluorescamine. · The 
electrophoresis was at 17 volts until the samples entered the separating gels after which the 
gel was run at 45 volts for 18 hours. The protein bands (in the reference wells) were· 
visualized under UV. The SOS-PAGE pattern of the fluorescamine treated sample was 
identical to that of untreated sample as established by Coomassie blue staining. The QPs3 
bands were sliced from the gels and then eluted from the gel slices with an electroelutor 
from Bio-Rad. The purity of subunit was judged by SOS-PAGE and coomassie blue 
staining. 
Production and Purification of Antibodies Against QPs3 
The eluted QPs3 was concentrated by membrane filtration, using centricon-10, to a 
protein concentration of 2 mg/ml and precipitated with cold acetone (-20 QC). The 
precipitates were washed with 50% acetone dried under argon, and suspended in PBS 
buffer to a protein concentration of 1.5 mg/mL. About 150 ug of QPs3 protein in 0.5 mL 
was emulsified with Freund' s adjuvant and injected into a NZW rabbit's back at several 
subcutaneous sites. Boosters were given weekly and blood was drawn from the ear. The 
serum was characterized by dot blot to monitor the appearance of antibodies. After the 
fourth booster blood was collected by cardiac puncture and serum was separated by clotting 
followed by centrifugation at 10,000 x g. Purification of antibodies was done as follows. 
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Sera were brought to 50% ammonium sulfate sat:uration with a neutralized saturated 
ammonium sulfate solution and centrifuged at 28,000 x g for 30 min. The precipitate was 
dissolved in 20 mM Tris-HCI, pH 8.0, containing 28 mM NaCl, and dialyzed overnight 
against the same buffer. Th~ dialyzed solution was centrifuged to remove undissolved 
particles and the clear supernatant was applied to a DEAE-affigel blue column equilibrated 
with 20 mM Tris-HCl, pH 8.0, containing 50 mM NaCl. This step primarily removes 
serum albumin which binds to the column and is separated from the IgG that is in the 
effluent. The effluent fractions with OD280 > 0,08 were pooled and concentrated using an 
Ultrafiltration cell with Amicon PM -:30 membrane followed by Centriprep-30 to a final 
volume of 2-3 ml and protein of >25 mg/mL. This IgG preparation contained a small 
population of IgM and further,purification of IgG was done by molecular sieving using 
Sephacryl S-300 SF column equilibrated with phosphate buffered saline (PBS). The 
purified IgG was concentrated to a protein of >5 mg/mL and stored at -80°C in the presence 
of 0.01 % sodium azide. 
Immunological Screening of a Bovine Heart cDNALibrary with Anti-QPs3 Antibodies. 
The beef heart cDNA expression library in 11.gtl l was screened with anti-QPs3 
antibodies according to reported methods (9, 10). Anti~QPs3 antibodies were preincubated 
with E.coli lysate (about 500 µg lysate protein to 1 µgantibody) for 2 hours at room 
temperature. The lysate treated antibody was filtered through a 0.2 µm membrane and used 
as a primary antibody along with goat anti-rabbit IgG aJ,kaline phosphatase conjugate as the 
secondary antibody in the screening procedures. BCIP and NBT were used for the alkaline 
phosphatase c~lorimetric detec~ion: 
Screening of cDNA Libraries by Plaque Hybridization. 
Two oligonucleotide probes with biotin label.at the 5' end were synthesized based 
on the partial N-terminal sequence obtained from microsequencing (see results section). 
Each of the probe was a guessmer encoding the N-terminal amino acids of QPs3. Probe 1. 
was 5' GTAGTCCATGGCTGAGCATGGCTTCAGGTAGGCAGCAGGGAT3' 
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complementary to the coding sequence of residues 24-37 (1-P-A-A-Y-L-N-P-C-S-A-M-D-
Y). Probe 2 was 5' GCTGCCTCCCTGCACTGGACAGGCGAGCGTGTGGTCTCTGT 
3' coding residues 5-14 (A-A-S-L-W-T-G-E-R-V-V-S). The screening and detection 
procedures were essentially as described by Martin et al. (11). 
Reductive Carboxymethylation and Succinylation of QPs3. 
The electrophoretically eluted QPs3 protein was concentrated by membrane 
filtration with centricon-10, to a final protein concentration of about 3 mg/ml and 
precipitated with 50% cold acetone (-20 °C). The protein precipitate was washed with cold 
water and dried under argon. The precipitate thus obtained was homogenized in O. lM 
Tris, 6M guanidine HCl, lmM EDTA, pH.8.3. ·oithiothreitol was added to the suspension 
to a final concentration of 2 mM. The mixture was made anaerobic by passing argon 
through it and then incubated at 37 °C for 1 hour. lodoacetic acid neutralized With NaOH, 
was added to give ~final concentration of 5 mM. The reaction mixture was flushed with 
argon and the container was sealed and alkylation was continued at 37 °C under dark 
conditions for 1 h. Additional treatment with 1 mM dithiothreitol and incubation with 2 
mM iodoacetate under the same conditions resulted in complete alkylation. 
The suspension of alkylated protein was treated with successive increments of 
succinic anhydride with constant stirring while maintaining the pH of the solution between 
7 and 8 by dropwise addition of 0.1 N NaOH. Each portion of the anhydride was allowed 
to completely react (as indicated by the cessation of acid production) before the next 
addition. After maximal clarification of the suspension was obtained, ~-mercaptoethanol 
was added to a final concentration of 1 % (v/v), and the solution was dialyzed against 50 
mM ammonium bicarbonate overnight. 
Proteolytic Cleavage of QPs3. 
The carboxymethylated and succinylated QPs3 protein was collected from the 
dialyzed sample by centrifugation at 100,000 x g for 20 min. The collectecl precipitates 
were suspended in 50 mM ammonium bicarbonate buffer, containing 1 M urea to a final 
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protein concentration of 1 mg/ml and digested with chymotrypsin at 37 °C for 2 h, using a 
chymotrypsin to QPs3 ratio of 1 :50 (w/w). After the 2-h incubation, a second addition of 
chymotrypsin was made (1: 100), and the digestion continued at 37 °C for 24 h. 
Isolation of QPs3 Peptides 
One hundred microliter aliquots of the chymotrypsin digested QPs3 protein were 
separated by reverse phase high performance liquid chromatography (HPLC) on a 
synchropak RP-8 column (0.46 x 25 cm) using a gradient formed from 90% acetonitrile in 
0.1 % trifluoroacetic acid and 0.1 % trifluoroacetic acid with a flow rate of 0.8 ml /min. 
Absorbance was monitored at 214 nm. The fractions at retention times of, 18.96, 32.15, 
and 34.21. were collected, dried, dissolved in 20% acetic acid and rechromatographed in the 
same system and used for sequence analyses at the Molecular Biology Resource Facility, 
Saint Francis Hospital of Tulsa Medical Research Institute, University of Oklahoma Health 
Sciences Center, under the supervision of Dr. Ken Jackson .. 
Results And Discussion 
Immunological Specificity of Anti-QPs3 Antibodies 
Anti-QPs3 antibodies obtained are immunologically specific as determined by 
western blots using QCR,SQR, purified QPsl, QPs2 a;nd QPs3 as antigens (Figure 7). 
Anti-QPs3 antibodies bind to the fourth and fifth subunits of SQR with equal intensity and 
to the purified QPs2 andQPs3. No binding to subunits of the QCR was observed. The 
cross reaction ofanti-QPs3 with QPs2 is not due to the cross contamination of QPs2 in 
QPs3 preparation used as antigen because the purity of QPs3 is evident from the 
preparation showing a single protein band corresponding to the fifth subunit of SQR in 
high resolution SDS-PAGE. The N-terminal amino acid sequence analysis showed only 
one peptide in the isolated sample. It should be noted that anti-QPs2 antibodies also reacted 
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equally well with QPs2 and QPs3 (12). Thus, the cross reaction may result from the 
sharing of common epitopes by these two proteins. 
Anti-QPs3 antibodies also reacted with unidentified high molecular weight E. coli 
Lysate proteins (>30 KDa) but did not react with any subunit of purified E. coli SQR. For 
this reason in all our library screening procedures anti-QPs3 antibodies were preincubated 
with E. coli lysate to remove the cross-reacting antibodies and thus avoid false positives in 
our screening experiments. 
Immunological Screening of cDNA Expression Libraries Using Anti-QPs3 Antibodies 
Since the amino acid sequences of the membrane-anchoring subunits in SQ Rs from 
different species show little conservation, homology probing method could not be used to 
obtain QPs3 cDNA. The availability of anti-QPs3 antibodies in our laboratory together 
with our previous success in immunological screening of a beef heart cDNA expression 
library in Agtl 1 to obtain cDNA for the Rieske iron sulfur protein (10), the QPc-9.5 kDa 
(13) ofQCR and QPsl (1) of SQR, encouraged us to attempt the immunological screening 
method to isolate the cDNA for QPs3. However no positive clone could be obtained. This 
failure to obtain cDNA for QPs3 by the immunological screening method was probably due 
to the low titer of antibodies against QPs3 rather than the lack of QPs3 cDNA in the cDNA 
library used because we also failed to obtain a positive clone from other beef heart cDNA 
libraries, such as in A.ZAP (from Stratagene). 
Partial Amino Terminal Sequence of QPs3 
. When purified QPs3 subunit (Figure 7) was sequenced a N-terminal sequence of 43 
residues was obtained:- NH2-:-S-G-S-K-A-A-S-L-H-W-T-G-E-R-V-V-S-V-L-L-L-G-L-I-
. . 
P-A-A-Y-L-N.:.P~C-S-A-M-D-Y-S-L-A-A-T-L-. Every sequencing cycle was clear without 
any background signal and surprisingly the noise was very low in the chromatograms. The 
success of the peptide sequencing was due to two important factors. The modification of 
QPs purification yielded pure protein in sufficient quantities. By using a hydrophobic 
column we were able to obtain an enriched QPs fraction. Since the SDH subunits are more 
30 
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Figure 7. Panel A shows the SDS-PAGE of molecular weight markers (lanel), ubiquinol 
cytochrome c reductase (lane 2), succinate-Q reductase (lane 3), isolated QPsl 
(lane 4), isolated QPs2 (lane 5), isolated QPs3 (lane 6); Panel B shows the 
Western Blot of A reacted with anti-QPs3 antibodies as the primary antibody 
and Protein-A horseradish peroxidase conjugate as the secondary antibody. 
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hydrophilic they did not bind to the hydrophobic column. Further the precasting and 
prerunning of acrylamide gels and the use of free radical scavenger, thioglycolate in the 
running buffers helped to prevent blocking of NH2 terminus of the protein and thus made the 
microsequencing possible. 
Previously a short stretch of QPs3 sequence has been reported as NH2-SDSKAASL 
by Dr. Capaldi's group (14). The amino acid at the second position is different from our 
sequence. This discrepancy is solved by the deduced amino acid sequence from our QPs3 
cDNA sequence. 
Isolation of the cDNA Encoding QPs3 From the Beef Heart cDNA Library in 11,ZAP by 
PCR Cloning 
Enzymatic amplification of specific cDNA inserts from11,gtll libraries has been 
reported (15). The design of synthetic guessmers requires knowledge of a partial amino 
acid sequence of the target protein. The success in obtaining a long and clear stretch of 
amino acid residues from microsequencing enabled the use of PCR cloning method to 
isolate the QPs3 cDNA from a beef heart cDNA library in ~AP, A 110-bp cDNA fragment 
was amplified from a beef heart cDNA library in ~AP (4x106 pfu) by PCR using two 
synthetic guessmers, 5'GCTGCCTCCCTGCACTGGAC3' (the sense primer) and 
5'GCAGCCAGGGAGTAGTCCAT3' (the antisense primer). The sense primer represents 
the guessed sequence for residues 5-11 (A5-A-S-L-H-W-Tll) with the degenerate third base 
of the codon of Tl 1 being omitted. The antisense primer represents the guessed sequence 
for residues 41-35 (A4l-A-L-S-Y-D-M35). Since Wand M have no degeneracy in their 
genetic codes, the presence of WlO and M35 in the QPs3 partial sequence enables us to 
design these two PCR guessmers with specificity at the 3' end: five specific bases in the 3' 
end of the sense guessmer and three in the antisense guessmer. The protocol for the 
isolation of QPs3 cDNA by PCR is summarized in Figure 8. 
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PCR amplification was performed in a minicycler from M. J. Research. The thermal 
cycle was set-up as follows: step 1, 95 °C for 3 min, step 2,. 94 °C for 1 min for 
denaturation; step 3,. 37 °C for 2 min for annealing; and step 4,. 70 °C for 90 second for 
extension. A total of 30 cycles were performed with a final extension step of 7 minutes. 
A 4x106 pfu of a cDNA library constructed in Uni-ZAP XR vector was used as 
template in the PCR reaction consisting of20mM Tris-HCl pH 83, 1.5 mM MgC12, 30 
mM KCl, 0;05% Tween 20, 100 ug of autoclaved gelatin, 100 µM of dNTP, 2 units of Tag 
polymerase, and 200 pmol of guessmers. The resulting 110-bp PCR product was cloned 
into aPCR vector (TA cloningkit}and sequenced. The DNA sequence of this 110-bp PCR · 
. . 
product translated to match the amino acid residues between TrplO and Met35 of the 
chemically determined partial N-terminal sequence ofQPs3. 
Based on the nucleotide sequence for residues 10-35 of QPs3, two gene specific 
primers, 5'TTGCTCCTGGGCCTAATTCC3', corresponding to residues 21-27 (sense 
primer), and 5' AGGAGCAAAACACTGAACAAC3', corresponding to residues 22-17 
(antisense primer) were synthesized and used with the vector ZAP's primers, T7 and T3, 
respectively, in the subsequent PCR reactions to yield 51 RACE and 3' RACE products. 
These two PCR products were cloned into the PCR II vector and sequenced. The 3' 
RACE product is confirmed by matching the deduced amino acid residues 21-42 of QPs3 
with chemically determined partial N-terminal amino acid sequence; and residues59-66 and 
44-49 with chymotryptic peptides of QPs3 with retention times of 18.96 and 31.15 min, 
respectively, on HPLC chromatogram. 
Sequence Analysis of QPs3 . 
Figure 9 shows the nucleotide sequence and the deduced amino acid sequence of 
QPs3, The QPs3 cDNA is 1330 base pairs long with an open reading frame of474 base 
pairs that encodes 158 amino acid residues: 103 of which, starting with serine, belong to 
mature QPs3, 55 of which, starting with methionine, constitute an N-terminal 
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Figure. 8 The Protocol To Isolate QPs3 cDNA by PCR Cloning 
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GAATTCGGCACGAG ATG GCT CTC TGG AGG·CTA AGT GTC CTC TGC GGC GCC AAA GAA GGG CGA 
met ala leu trp arg leu ser val leu cys gly ala lys glu gly arg 
GCT CTG TTC CTC CGA·ACC CCA GTG GTC AGA CCA GCT CTT GTC TCA GCA TTT CTC CAG GAC 
ala leu phe leu arg thr pro val val arg pro ala leu val ser ala phe leu gln asp 
CGA CCT GCT CAA GGA TGG TGT GGA ACA CAG.CAT ATT CAC CTG TCA CCC AGC CAC CAT 
arg pro ala gln gly trp cys gly thr gln his ile his leu ser proser his his 
1 11 
TCT GGT TCC AAG GCT GCA TCT CTC CAC TGG ACT GGT GAG AGG GTT GTC AGT GTT TTG CTC 
ser gly ser lys ala ala ser leu his trp thr gly glu arg val val ser val leu leu 
21 31 
CTG GGC CTA ATT CCA GCT GCA TAT TTG AAT CCG TGT TCT GCG ATG GAC TAC TCT CTG GCT 
leu gly leu ile pro ala ala tyr leu asn pro cys ser ala met asp tyr ser leu ala 
41 51 
GCA ACC CTC ACT CTT CAC AGT CAC TGG GGC ATT GGA CAA GTT GTT ACT GAC TAT GTT CAT 
ala thr leu thr leu hisser his trp gly ile gly gln val val thr asp tyr val his 
61 71 
GGA GAT GCA GTG CAG AAA GCT GCC AAG ACA GGC CTG TTG GTG CTC TCG GCT TTC ACC TTT 
gly asp ala val gln lys ala ala lys thr gly leu leu val leu ser ala phe thr phe 
81 91 
GCT GGG CTC TGT TAC TTC AAC TAT CAT GAC GTG GGC ATC TGC AAA GCTGTG GCT ATG CTG 
ala gly leu cys tyr phe asn tyr his asp val gly ile cys lys ala val ala met leu 
101 
TGG AAG CTC TGA 













Figure 9. The nucleotide sequence of cDNA encoding bovine QPs3 and the deduced amino 
acid sequence. The first amino terminal residue serine of mature QPs3 is 
marked as 1. The cDNA sequence has been submitted to the GENBANK 
database with accession number U50987 
presequence. In addition, the cDNA has 820 nucleotides of 3' non-coding sequence and 
contains a poly(A) tail. 
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The presequence of QPs3 is rich in the basic amino acid arginine and contains the 
hydroxyl amino acid serine. This is characteristic of the cleavable amino terminal 
presequences that are essential for the import of mitochondrial proteins encoded by nuclear 
DNA (16). Since the QPs3 presequence lacks arginine at the ".'2 position relative to the 
mature amino terminus, QPs3 may be matured by a two-step cleavage process (17). 
Mitochondrial- proteins with leader peptides containing the R,X-(F)-X-X-(S) motif, where 
R= arginine at the -10 position, X=other amino acid at -9 ; (F)= hydrophobic residues at -8 
; and (S)= serine, threonine or glycine at -5, are thought to cleave first by a matrix 
processing protease between residues at -9 and -8, sirice arginine at position -10 is at 
position-2 relative to the cleaved bond. The remaining octapeptide is subsequently 
removed by an intermediate-specific protease. Although the QPs3 presequence lacks the 
arginine- IO in the common motif of this two-step cleavage, the maturation of QPs3 may still 
follow the same process because mutation of arginine-IO in the human ornithine 
transcarbamylase precursor or rat malate dehydrogenase precursor, to alanine (18, 19) does 
not alter the two step maturation of these two proteins. 
The molecular weight of mature QPs3, deteniiined from the deduced amino acid 
sequence, is 10,989 daltons, which is fairly close to the 9 kDa estimated from SOS-PAGE. 
Figure 10 compares the amino acid sequence of bovine QPs3 with those of S. cerevisiae 
SDH4 (20), adult A. suum cytbS (21), E. coli SDHD (22) and FRDD (23). Bovine QPs3 
shares no sequence homology with gene products of S. cerevisiae sdh4, E. coli sdhD and 
frdD, but has 50% sequence identity with theA suum (adult) cytochrome b small subunit 
of fumarate reductase (20). It is noteworthy that the similarity between bovine QPs3 and 
A. suum cybS is greatest in the region from Leu-23 to His-60 of QPs3 (68% ). This 









































Figure 10. Comparison of the peptide sequences of the smallest membrane anchor 
subunits of succinate-Q reductases from different species. Amino acid 
residues to those identical in QPs3 are boxed. 
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provides the heme b ligand (24). His-81 of E. coli FRDD that was reported to be 
involved in Q-binding is also in this region (25). The QPs3 cDNA was found to have 85% 
sequence identity to the DNA sequence of a Homo Sapiens cDNA clone (R91018) 
according to a BLAST search of the Expressed Sequence Tag (EST) database. 
Chapter .Summary 
The cDNA encoding the smallest membrane anchoring subunit (QPs3) of bovine 
heart mitochondrial SQR was cloned and sequenced. This cDNA is 1330 base pairs long 
with an open reading frame of474 base pairs that encodes the 103 amino acid residues of 
mature QPs3 and a 55 amino acid residue presequence. The cDNA has a 820 base pair 
long 3' untranslated region, including a poly(A) tail. The molecular mass of QPs3 is 
calculated as 10,989 Da. QPs3 has no sequence identity to SDHD of E. coli SQR in 
contrast to QPsl which shares more than 40% sequence identity with SDHC. QPs3, 
however shares more than 50% identity with the smallest anchor subunit of FRD from A. 
suum (adult). QPs3 cDNA is also found to be related to a human cDNA clone reported in 
the EST database. 
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Glutaraldehyde, enzyme grade horseradish permtjdase, bovine serum albumin, 
. . 
· dichlorophenolindophenol, Triton X...;100, sodium cholate, were purchased from Sigma. 
Protein A-horseradish peroxidase conjugate, Low range SOS-PAGE molecular weight 
markers, DEAE-Affigel blue, were from Biorad'. Sephacryl separation matrices were from 
Pharmacia. Peptides were synthesized by the Recombinant DNA/Protein Resource Facility 
at Oklahoma State University. 
Enzyme Preparations and Assays 
Intact mitochondria (5), mitoplasts (6),, submitochondrial particles (7)and SQR (8) were 
prepared and assayed byreported methods. SQRwas assayed for its·ability to catalyze Q 
reduction or Q-stiinulated DCPIP reduction by succinate. The assays were performed at 
. . 
room temperature in a Shimadzu UV-2101PC. The reaction mixture used for Q-stimuiated 
DCPIP reduction assay contains '38µrnol of DCPIP, 100 µmol of sodium/potassium 
phosphate buffer, pH 7.4, 20 µmol of succinate, 10 nmol of EDTA,_25 nmol of Q0C10 and 
0.01 % Triton X-100 in the total volume of 1 ml. The reduction of DCPIP was followed by 
· measuring the absorption decrease at 600 nm, using a millimolar extinction coefficient of 
21 rnM·1cm·1• Protein concentration was determined by the Lowry method (9). Western 
blotting was performed according to a published method (10). . 
Production and Purification of Antibodies Against QPs3 N-terminal·and Connecting 
·Peptides 
Three polypeptides, on~ containing_ 14 amino acid residues (1'lH2-S-G-S-K-A-A-S-
L-H-W-T-G-E-R-COOH) corresponding to residues 1-14 of QPs3 (the N-terminal peptide, 
see Figure 13), another peptide containing 11 amino acid residues (NH2-T-D-Y-V-H-G-D-
A-V-Q-K-COOH) corresponding to residues 56-66 (the connecting peptide, the loop 
between helices 2 and 3, see Figure 13) and a third containing 14 residues corresponding. to 
42 
the C-terminal residues 90-103 (NH2-H-D-V-G-I-C-K-A-V-A-M-L-W-K-L-COOH) were 
synthesized. These peptides were conjugated to carrier protein (Scheme I) ovalbumin 
using the homobifunctional reagent, glutaraldehyde, as described below. The solubility.of 
the synthetic peptide was tested in wateraridPBS buffer, pH 7.8. The peptide solution 
was mixed with ovalbumin in the weight ratio 1: 1 at:1d molar ratio of 50 moles peptide/I 
mole carrier. The mixture was slowly stirred on ice and an equal volume of 2% solution of 
glutaraldehyde was added dropwise. The mixture was stirred at O '?C for about 2 hours 
after which about 3 mg of sodium borohydride for every mL solution was added in small 
increments and the mixture was continuously stirred for 30 min. The coupled peptide-
carrier solution was dialyzed against PBS buffer with frequentchanges of buffer and . 
concentrated with centricon and stored at4 °C for future use. The coupling reaction was 
verified by running an aliquot of coupled antigen on a 12 % SDS~PAGE and comparing 
with the same amount of carrier protein only. About 150 µg of coupled protein was used 
as antigen to raise monospecific polyclonal antibodies in rabbits. Boosters were given 
weekly for 5 weeks, and sera were collected.by cardiac puncture. Purification of 
antibodies was performed as described in chapter I. Control antibodies were prepared in 
·the same manner from serum from the respective rabbit taken prior to immunization. 
Characterization of antibodies was done by western blots using SQR and pure QPs 
subunits as antigens. 
·. Preparation of Fab' Fragment-Horseradish Peroxidase Conjugates of Anti-QPs3 
Antibodies 
. F(ab')2 and F(ab') fragments were prepared by pepsin digestionoflgGaccotding to the 
. . 
methods of Stanwotth and Turner (11} and Taniguchi et al.{12), respectively. 
Specifically, two mg of horseradish peroxidase (type II, Sigma) dissolved in 0.3 ml ofO. l 
M sodium phosphate, pH 7 .0, was mixed with 20 µl of a coupling reagent, 4-(N-
maleimidomethyl)-cyclohexane-1-carboxylic acid N-hydroxysuccinimide ester in N,N-
dimethylformamide, and incubated at 30°C for 45 min. After centrifugation at 10,000 x g . 
the supernatant solution was applied to a Sephadex G-25 column equilibrated with 0.1 M 
sodium phosphate, pH 6.0, to remove excess coupling reagent. Peroxida,se with 
maleimide groups was collected and concentrated to a protein concentration of 4 nig/ml. 
. . . . 
Fab' fragment was prepared by red1,1cing the cystine groups of F(ab)2 to cysteine using a 
. . 
100 times molar excess of 2-mercaptoethanol. After2 hours of 30 °C incubation the 
mixture was applied to a Sephadex G-25 column equilibratedwith 0.1 M sodium 
. . . 
phosphate, pH6.0, containing 5 mM EDTAto remove the 2-mer~aptoethanol. Fab' was 
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collected and adjusted to a protein concentration of 5 mg/ml. The fr~shly p~epared Fab' 
fragment (25mg) was mixed with the derivatized peroxidase (2 mg) and incubated at 4°C 
for 20 hours. Fab' -HRP, conjugate was separated on a Sephacryl S-200 HR column in 0.1 
M sodium phosphate, pH 6.5. The horseradish peroxidase activity of the purified 
conjugate was assayed, usingaTMB peroxidase substrate kit (Bio-Rad), according to the 
manufacturer's instructions. 
. .. 
Results and· Discussions 
Preparation of QPs3 Peptide Antigens and Immunological Specificity of Anti-QPs3 
Peptide-Antibodies 
The preparation of peptide antigen by coupling to glutaraldehyde and the 
preparation of Fab' .:.horseradish peroxidase is outlined in Schemes I and II, respectively .. 
The advantages of using Fab' -HRP conjugate art:? two-fold: (I) the antibody fragment 
conjugate has easy access to the epitopes of the antigen in our membrane preparation 
because of its smaller molecular size than the whole IgG; (ii) the amount of conjugate 
bound to the antigen can be estimated' by assaying the horseradish peroxidase activity. 
The N-terminal peptide and the connecting peptide could be successfully coupled to 
ovalbumin (Coupled antigen-ovalbumin showed a decreased mobility on SOS-PAGE than 
· ovalbumin alone) and were injected into rabbits to produce monospecific polyclonal anti-
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Scheme I 
Production of Monospecific Polyclonal Antibodies Against QPs3 Peptides. 
Synthesis of Antigenic Peptides · 
Chemical cof pling to Carrier Protein 
Glutaraldehyde, Homobifunctional coupling 
Peptide : Carrier : : 50: 1, molar ratio 
· stir gently at O °C; add 1 volume of 2% 
glutaraldehyde and stir a:t O °C 
_Dialysis or gel filtration to remove unreacted 
peptides 
. Emulsion of peptide-carrierin Freund' s adjuvant 
l 
Subcutaneous Injection of Antigen into Rabbits 
. Collection of Blood 
! 
Purification of IgG from Sera 
Characterization using SQR as Antigen 
Scheme IL 
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Figure 11. Western Blot Analyses of Antibodies Against N-terminal and Connecting 
Peptides of QPs3. Panel A, SDS-PAGE of molecular weight standards (lane 
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1), ubiquinol-cytochrome c reductase (50 µg, lane 2), succinate-Q reductase (26 
µg, lane 3), purified QPsl (7 µg , lane 4), QPs2 (6 µg, lane 5), and QPs3 (8 
µg, lane 6). The proteins on the gel of panel A were electrophoretically 
transferred to a nitrocellulose membrane without staining and then incubated 
with, antibodies against the N-terrninal peptide (panel B), and antibodies against 
the connecting peptide (panel C).Protein A Horseradish peroxidase conjugate 
was used as second antibody. 
47. 
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Figure 12. The Proposed Structural ModeLof QPs3 in the Inner Mitochondrial Membrane 
Figure 13. Binding of Fab' fragment-horseradish peroxidaseconjugates prepared from 
antibodies against QPs3, the N-terminal and connecting peptide of QPs3 with 
mitoplasts, submitochondrial particles, and alkali treated submitochondrial 
particles. The indicated amounts of mitoplasts ( §), submitochondrial 
particles ( Hill), and alkaline-treated submitochondrial particles ( m) were mixed 
with 10 milliunits of Fab-horseradish peroxidase conjugates prepared from 
anti-QPs3 antibodies (A), anti-N-terminal peptide antibodies (B), and anti-
connecting peptide antibodies (C) in 50 mM sodium phosphate, pH 7.4, 
containing 0.25 M sucrose and incubated at 4 °C for 3 h. The mixtures were 
centrifuged at 30,000 x g for 15 min, and the precipitate was suspended in 50 
mM sodium phosphate, pH 7.4, containing 0.25 M ~ucrose. This procedure 
was repeated three more times before aliquots of the suspension were taken 
and horseradish peroxidase activity was assayed; Preimmune Fab'-
horseradish peroxidase conjugate treated with mitoplasts, submitochondrial 
particles and alkali-treated SMP in the identical manner was used as control. 


























QPs3 antibodies. However, the C-terminal peptide was insoluble in buffers above pH 6.0 
and hence coµld not be successfully coupled to the carrier. 
The antibodies against QPs3, N-terminal peptide and connecting peptide were tested 
for their specificity in a western blot using antigens namely; QCR, SQR, and purified 
QPsl, QPs2, and QPs3 (Figures 7 and 11) 
It should be mentioned that during the course of immunological studies of QPs3 we 
observed that antibodies against QPS3, the N-terminal, and the connecting peptides cross 
react with QPs2{see lanes 3, 5, & 6in Panels B of figure 6 and, C, & D of Figure 11). 
They do not react with QPsl or proteins in QCR (see Figure 11). These results suggest 
that QPs2 and QPs3 have several common epitopes. 
The Proposed Structure of 0Ps3 in the Mitochondrial Inner Membrane 
Figure 12 .shows the proposed structure of QPs3 in the inner mitochondrial 
membrane. This structural model, was constructed based on hydropathy plots of the amino 
acid sequence of QPs3, predicted tendencies to form a-helices and ~-sheets, .and the 
binding of Fab' fragment-horseradish peroxidase conjugates, prepared from antibodies 
against synthetic peptides corresponding to residues 1-14 and 55-66 of QPs3, in 
mitoplasts, submitochondrial particles (SMP), and alkali-treated submitochondrial particles. 
In this model QPs3 has three transmembrane helices corresponding to residues 15-34 (helix 
. I), 37-56 (helix II) and 67-89 {helix III). The N-terminus region, residues 1-14, and the 
loop connecting helices U and ill, residues 57-66, are extruded from the M.:. ··· 
side of the inner mitochondrial membrane. The loop connecting helices I and II, residues 
36-37, and the C-terminus region, residues90-l03, are on the C-side of the membrane. 
The sidedne~s of the membrane in this model was :determined immunologically with 
Fab'-horseradish peroxidase conjugates prepared from anti-QPs3, anti-N-:terminus peptide 
(residues 1-14), and anti-connecting peptide (residues 57-66) antibodies, in bovine heart 
mitoplasts (digitonin-treated intact mitochondria), submitochondrial particles (SMP) 
(reverse orientation), and alkaline treated SMP (SMP devoid of succinate dehydrogenase). 
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The peroxidase activity assays of these three particles are shown in Figure 13. Since the 
peroxidase activity observed with preimmune Fab'-horseradish peroxidase-treated 
preparations is assumed to be due to nonspecific binding, it is subtracted from that of the 
anti-QPs3, anti-N-termii:ms·peptide, or anti-conll,ectingpeptide Fab'-horseradish 
peroxidase-treated preparations; · The intactness of mitoplasts and submitochondrial particle 
preparations was established by the absence and presence of rotenone-sensitive NADH-Q 
reductase activity. 
When mitoplasts and SMP preparations were treate.d with anti-QPs3 Fab' fragment-
peroxidase conjugates, peroxidase activity was detected in both. preparations. The slightly 
· higher activity in treated SMP suggests that QPs3 is a t:ransmembranous protein with 
slightly more mass exposed on the matrix side bf the membrane. When an alkali-treated 
. . 
SMP preparation is treated with anti-QPs3 Fab' fr~gment-horserndish peroxidase 
conjugate, only a slight increase in peroxidase activity is observed, indicating tl:l.at few 
epitopes on the matrix side of QPs3 are covered by succinate dehrdrogenase .. 
When mitoplasts and SMP preparations are treated with Fab' fragment-horseradish 
peroxidase conjugates prepared from anti-N-terminaland connecting peptides antibodies, 
peroxidase activity was observed only on SMP, indicating that the N-terminal end and the 
loop.connecting helices Iland ill are exposed on the M-side of the mitochondrial inner 
membrane. 
·. Chapter Summary 
The topology. of QPs3 in the inner mitochondrial membrane was studied using an 
immunological approach. The structure of QPs3 in the inner mitochondrial membrane is 
proposed based on the hydropathy profile of the amino acid sequence, predicted tendencies . 
to form a-helices, and ~-sheets, and on immunobinding ofFab' fragment-horseradish 
peroxidase conjugates prepared frrom antibodies against two synthetic peptides, 
corresponding to the N-terminus region and the loop connecting helices 2 and 3 of QPs3, 
51 
in mitoplasts and submitochondrial particles. Accordingly QPs3 has three transmembrane 
segments with its amino terminus exposed to the matrix side, and carboxy terminus 
exposed to the cytoplasmic side. 
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CHAPTER III 
. IDENTIFICATION OF THE UBIQUINONE-BINDING DOMAIN IN QPs3 
OF SUCCINATE-Q. REDUCT ASE · 
When a succinate-free, partially Q-deficient SQR is treated with [3H]azido-Q 
derivatives in the dark followed by illumination with a long wavelength UV light , about 
50% of bound Q is located on QPs 1.and the other50% is equally distributed between QPs2 
and QPs3 (1). Although lesser amounts ofazido-Q were found in QPs2 and QPs3, 
involvement of these two subunits in the Q-binding site cannot be ruled out. The low 
azido-Q uptake by QPs2 and QPs3 may result from (i) only part of a Q-binding site being 
formed by these two subunits; (ii) preferential binding of these two subunits by 
endogenous Q present in the partially Q-deficient SQR used in these photoaffinity labeling 
studies; or (iii) QPs2 and QPs3 being the same peptide, i.e., either QPs2 is incompletely 
processed QPs3 or QPs3 is a C-terminal truncate of QPs2. If the latter is true, the amount 
of azido-Q uptake by QPs2 or QPs3 equals that by QPsl. Isolation of an azido-Q-linked 
peptide from azido-Q-labeled QPs2 orQPs3, obtained from azido-Q-labeled succinate-Q 
. .. . : 
reductase, will help determine the Q-binding role of QPs2 or QPs3. In this chapter, I 
report the isolation and partial N-terminal sequence of azido-Q-1inked peptides from labeled 
. . ., . '. . 




Bovine serum albumin, DCPIP, Triton X-100, sodium cholate, Phenyl Sepharose 
CL-4B, TTFA, and deoxycholic acid were obtained from Sigma. n-Dodecyl-~-D-maltoside 
was from Anatrace. Insta-gel liquid scintillation cocktail was from Packard Instrument Co. 
The ubiquinone derivatives, 2,3-dimethoxy-5-methyl-6~decyl-1,4-benzoquinone 
(QoC10) and 3-azido-2-methyl-5-methoxy- and 3-azido-2-methyl-5-methoxy[3H]-6-decyl-
1,4-benzoquinohe {azido-Q and [3H]azido-Q} were synthesized in our laboratory 
according to previously reported methods (1) and are briefly described below. Calcium 
phosphate was prepared according to Jenner and mixed at a 3: 1 ratio with cellulose powder 
prior to use in column chromatography. 
Synthesis of 3-Azido-2-Methyl-5-Methoxy-6-Geranyl-and 3-Azido-2-Methyl-5-Methoxy-
6-(3, 7-Diethyl[3H]-Octyl)- l ,4-Benzoquinones (azido:-0 and [3H]Azido-0) 
Six grams of 4-methyl-3-nitroanisole were mixed with lg of 10% Pd-C in 95 ml of 
methanol. After the addition of 5 ml of methanol-HCI (2.47 M), the reaction was carried 
out for 40 min at 2 atm hydrogen pressure in a Parr shaker. The methanol solvent was 
evaporated in vacuo and the deep greenish oil was dissolved in 600 ml of cold 0.5 M 
sulfuric acid. Then 250 ml of a cold solution containing 27 g sodium dichromate and 20 ml 
concentrated sufuric acid was added slowly with stirring, the temperature being maintained 
at about 5 °C. After stirring for 4 hours at room temperature the mixture was extracted with 
200 ml methanol four times. The combined deep brown extract was stirred with increasing 
amounts of florisil until the color of the solution became yellowish; florisil was removed by 
filtration. Upon removal of methanol, 0.5 g of yellow crystals of 2-methyl-5-methoxy-1, 
4-benzoquinone were obtained. 
Sixty mg of 2-methyl-5-methoxy-1, 4-benzoquinone was dissolved in 20 ml of 
diethyl ether and shaken with 0.5 g sodium dithionite in 4 ml water until the solution 
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became colorless. The mixture was extracted with diethyl ether. The reduced 
benzoquinone, obtained as colorless crystals upon removal of solvent, was dissolved in 4 
ml of dioxane, mixed with 80 ml of geraniol, and treated with 100 ml of BF30(C2H5)2for 
30 min with stirring. The mixture was stirred for 3 hours at room temperature, treated with 
12 ml of water, and extracted with diethylether. The ether extract was dried over Na2S04 
and oxidized with 0.1 g of Ag20 for 1 hour with stirring. The solution was filtered and the 
. filtrate was purified by silica gel G plates developed with hexane/diethylether (3.5: 1). 2-
Methyl-5-methoxy-6-geranyl-1,4-benzoquinone has an RF value of0.67. A by~product, 2-
methoxy-5-methyl-6-geranyl-'l,4-benzoquinone, with an RF value of 0.22, was also 
detected on the thin layer chromatogram. 2-Methyl-5-methoxy-6-geranyl-1,4-benzoquinone 
was eluted with ether and upon removal of solvent, 9 mg of orange oil was obtained. 1H-
NMR{CDC13): 6.42,(q,l), 5.06 (t,2}, 4.01 (s,3), 3.18 (d,2), 2.02 (m,7), 1.66 (t,9). 
UV max (95% ethanol): Ox., 263 nm; Rd., 288 nm; high resolution mass spectra, m/e, 
288.1695. 
For the synthesis of 3-azido-2-methyl..:5-methoxy-6-geranyl-1,4-benzoquinone, 25 
mg of 2-methyl-5-methoxy-6c.geranyl-l ,4-benzoquinone was dissolved in 1 ml of acetic 
acid (90% ), and incubated at 75 °C with constant stirring. The subsequent steps were 
performed in the dark. Three additions of sodium azide solution ( 17 mg sodium azide in 
water) were made over a period of 3 hours. Then the mixture was stirred for 7 hours at 75 
°C, concentrated, and purified by thin layer chromatography using the same solvent. The 
sample was eluted from the plate with ether. Upon removal of ether, 0.5 mg of pure 3-
azido-2-methyl-5-methoxy-6-geranyl-1,4-benzoquinone was obtained. lH-NMR (CDC13): 
1.66,(t,9), L98 (m,7), 3.16 (d,2), 3.98 (s,3), 5.04 (t,2), 1.66 (t,9). UVmax (95% 
ethanol): Ox., 306 nm; Rd., 298 nm. 
The 3-azido-2-methyl-5-methoxy-6-(3 ,7-dimethy 1[3H]-octyl)-1,4-benzoquinone 
was obtained via hydrogenation of 2-methyl-5-methoxy-6~geranyl-1,4-benzoquinone with 
tritiated hydrogen gas followed by azodilization with sodium azide. The tritiated gas was 
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generated from tritiated water by addition of metallic sodium in one arm of the H-shaped 
apparatus after evacuation. Metallic sodium was hooked by a movable wire through a 
silicone plug. The amount of tritiated water used was calculated to be enough to generate a 
pressure of 3 atm of tritiated hydrogen in the apparatus. 2-Methyl-5-methoxy-6-geranyl-
1,4-:benzoquinone and Pd/C were mixed and placed in the other arm of the H-shaped 
apparatus and the whole system was subjected to evacuation. During the evacuation the 
arm containing tritiated water was placed in a dry ice- acetone bath to decrease evaporation. 
After evacuation the metallic sodium was slowly lowered into the water to generate the 
tritiated hydrogen gas. The hydrogenation was completed in 3 hours at room temperature 
with vigorous shaking. Specific radioactivity for the 3-azido-2-methyl-5-methoxy-6-(3,7-
dimethyl[3H]-octyl)-l,4-benzoquinone was55,000 cpm I nmol, determined in a Beckman 
liquid scintillation counter. 
Enzyme Preparation and Assays 
Submitochondrial particles (2), and SQR (3) were prepared and assayed as 
previously reported. SQR was assayed, at room temperature, for its ability to catalyze 
TTFA sensitive Q-stimulated DCPIP reduction by succinate, using a Shimadzu UV-
2101PC. The reaction mixture (1 ml) contained 40 µmol ofDCPIP, 100 µmol of sodium 
potassium phosphate buffer, pH 7.4, 20 µmol of succinate, 10 nmol of EDTA, 25 nmol of 
QoC10 and 0.01 % of Triton X-100. The reduction of DCPIP was followed by measuring 
the absorption decrease at 600 nm, using a millimolar extinction coefficient of 21 
mmol""1cm·1• The concentrationof TTFA used was 10·4 M. 
Isolation of [3H]azido-Q-labeled0Ps2 and QPs3 from [3H]azido-0 SOR 
Purified SQR was photoaffinity labeled with the [3H]azido-Q derivative as reported 
previously (1). The azido-Q-labeled reductase was precipitated by 43% saturation of 
ammonium sulfate, separated by centrifugation at 48,000 x g for 20 min, dissolved in 20 
mM Tris-Cl, pH 7 .8, and dialyzed against double-distilled water overnight, with one 
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change of water. [3H]azido~Q-labeled QPs3 was purified to homogeneity from this 
dialyzed, labeled succinate-Q reductase. Succinate-Q reductase was diluted to 2 mg/ml 
with 50 mM Tris-HCl, pH 7.4, contai_ning 0.2% sodium cholate. The solution was stirred 
at room temperature for 30 min and applied to .a phenyl-sepharose CL-4B column · 
equilibrated with 50 mM Tris-HCl, pH 7.4, containing 0.2% sodium cholate. The column 
was, in sequence, washed with 50 mMTris-HCl, pH 7.4, containing 0.2% sodium 
cholate~ 50 mM"Tris-HCl, pH 7.4, containing 2%sodium cholate and 4 M urea, and 50 
. . 
mM Tris-HCl, pH7.4, containing 0.2% sodium cholate. QPs was eluted from the column 
with 50 mM Tris-HCl, pH 7.4, containing 0.15% SDS~ Pure QPs3 was obtained from 
QPs by preparative SDS-P AGE essentially according to the previously reported method 
(Chapter I). 
Reductive Carboxymethylation and Succinylation.of Azido-Q labeled QPs2 and QPs3 
The electrophoretically eluted [3H]azido-Q-labeled QPs2 and QPs3 were 
. concentrated by membrane filtration .with centn,con:.10, to a final protein concentration of 
about 3 mg/ml and precipitated with 50% cold acetone (-20 °C). The protein precipitate 
was washed with cold water and dried under argori. The precipitate thus obtained was 
homogenized in O.lM Tris, 6M guanidine HCl, lmM EDTA, pH 8.3. Dithiothreitol was 
added to the suspension to a final concentration of 2 mM. The mixture was made anaerobic 
by passing argon through itan~ then incubated at 37 °C for 1 hour. Iodoacetic acid 
neutralized with NaOH, .was added to give a final concentration of 5 mM. The reaction 
mixture was flushed with argon and the container:was sealed and alkylation was continued 
at 37 °C under dark conditions.for J h. Additional treatment with 1 mM dithiothreitol and 
incubation with 2 mM iodoacetate under same conditions resulted in complete alkylation. · 
The suspension of alkylated protein was treated with successive increments of 
succinic anhydride with constant stirring while maintaining the pH of the solution between 
7 and 8 by dropwise addition of 0.1 N NaOH. Each portion of the anhydride was allowed 
to completely react(as indicated by the cessation of acid production) before the next 
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addition. After maximal clarification of the suspension was obtained, ~-mercaptoethanol 
was added to a fmal concentration of 1 % (v/v), and the ·solution was dialyzed against 50 
. mM ammonium bicarbonate overnight. 
Chymotzypsin Digestion of Carboxymethylated and Succinylated [3H]azido4inked QPs2 
andQPs3 
The reductive· carboxyrnethylated and ~uccinylated QPs2 and QPs3, 1 mg/ml, 
suspended.in 50 mM ammonium bicarbonate buffet, containing l M urea were treated with 
chymotrypsin at 37 °C for 2 h, using a chymotrypsin to QPs3 ratio of l:50 (w/w). After 
the 2-h incubation, a second addition of chymot:rypsin was made ( 1: 100), and the digestion 
continued at 37 °C for 24 h. 
Isolation of [3If]Azido~Q-Linked Peptides · 
One hundredmicroliter aliquots of the chym~trypsin digested, reductive 
carboxymethylated, succinylated, [3H]azido-Q~labeled QPs3 and [3H]azid~-Q~labeled 
QPs2 were separated by reverse phase high performance liquid chromatography (HPLC) 
on a Synchropak RP..:8 column (0.46 x 25 cm) using a gradient formed from 90% 
acetonitrile in 0.1 % trifluoroacetic acid and 0.1 % trifluoroacetic acid with a flow rate of 0.8 
ml /min. 0.8 ml fractions were collected and monitored for radioactivity and absorbance at 
214 nm. Fractions with radjoactivity were collected, dried, and sequenced. Those 
containing noradfoactivity, with retention times ofl8.96 andJ.1.15 were also collected, 
. ' \ . . ' . . . 
. dried, and sequenced .. 
Amino Acid Sequence Determination·• · 
These ~alyses were done at the Molecular Biology Resource Facility, Saint Francis 
. . 
. . 
Hospital of Tulsa Medical Research Institute, University of Oklahoma Health Sciences 
Center, under the supervision of Dr. Ken Jackson. 
Results and Discussion 
Isolation and Characterization of the Ubiquinone-Binding Peptides of QPs3. 
[3H]azido-Q-labeled QPs3 was isolated from [3H]azido-Q labeled succinate-Q 
reductase by a procedure involving phenyl-sepharose CL-4B column chromatography, 
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preparative SDS-PAGE , electrophoretic elution of proteins from.gel slices, and acetone 
precipitation (Scheme ID). The use of a hydrophobic column, phenyl-sepharose CL-4B, 
and elution with different detergents resuled in the isolation of [3H]..,azido-Q-labeled QPs 
from [3H]azido-Q labeled succinate-Q reductase. Since the FP and IP subunits of succinate 
dehydrogenase are less hydrophobic than those of QPs subunits, they were eluted with 
detergents having less hydrophobicity than that used for eluting QPs. This column 
chromatographic step also removed most of the non-protein bound [3H]azido-Q from QPs. 
Pure [3H]azido-Q-labeled QPs2 and QPs3 were isolated from the labeled QPs by 
preparative SDS-PAGE using a high resolution gel·system in the presence of 8 M urea. 
The use of preparative SDS-PAGE not only separated QPs3 from other QPs subunits, it 
also further removed non-protein bound azido Q adducts from QPs3. QPs2 and QPs3in 
gel slices were obtained by electrophoretic eluting. The SDS present in the eluted protein 
solution was removed by 50% acetone precipitation. 
Although the isolated [3H]azido-'Q-labeled QPs3 is pure and free of free azido-Q, it 
is highly aggregated and resistant to proteolytic enzyme digestion. Inclusion of 0.1 % SDS 
. . .. 
and 2 M urea in the digestion mixture did not increase proteolysis. Modification of isolated 
azido-Q labeled QPs3 by reductive carboxymethylation followed by succinylation rendered 
the protein susceptible to·chymotrypsin digestion. Reductive carboxymethylated and 
succinylated QPs3 was not completely soluble in aqueous solution; the solution became 
clear only after chymotrypsin digestion. A similar situation was observed with azido-Q 
labeled-cytochrome b (4). 
Scheme III 
Isolation of Azido Q-labeled QPs3 and QJ>s2 Peptides 
Succinate-Free SQR+azido-Q (1:10) 
incubate on ice for20 min 
·. . . 
. . . Shine UVJight for 7 nlin 
Dialyze against ·w~ter overnight 
· Azido-Q.;Iabeled SQR 
* Phenyl.sepharose column chromatography. 
QPs fraction 
Preparative SOS-PAGE 
Electroehition, acetone precipitation 
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.... Chemical modification, Proteolytic deavage 
· HPLC separation of peptides 
. Determine the radioactivity distribution 
Accumulate peptide fraction(s) with 
· radioactivity 
Peptide Sequencing 
Azido-Q Linked peptide 
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Figure 14 shows the distribution of radioactivity amon.g the chymotryptic peptides 
of QPs3, and QPs2 separated by HPLC. Most of the radioactivity was found in fraction 66 
(P-66). The HPLC chromatograms and radioactivity distribution of the chymotryptic 
peptides of QPs2 are identical to.those of QPs3. 
When P-66 from QPs3 was sequenced, a partial N-terminal sequence of Leu.:.Asn-
Pro-Cys-Ser-Ala-Met-Asp-Tyr, corresponding to residues 29-37 inQPs3, was obtained. 
An identical sequence was obtained for the radioactivity containing fraction from QPs2. 
Thus the Q-binding domain in the proposed structure of QPs3, is probably located at the 
end of transmembrane helix 1, near the C-side of the membrane. The sequencing of a 
[3H}-azido-Q-labeled QPsl peptide yielded a sequence ofGly-Leu-Thr-Ile-Ser-Gln, which 
is a region exposed on the matrix side of the membrane. 
The finding that theQ-binding domains in QPs3 and QPsl of bovine succinate-:Q 
reductase are on the opposite sides of the membrane is consistent with a two-Q binding site 
hypothesis formulated from inhibitor studies of this enzyme complex (5). The presence of 
two quinone-binding sites in E. coli fumarate reductase is suggested by mutational studies 
(6) and by inhibitor kinetic analysis of putative Q~binding site mutants (5). When these 
two quinone binding sites in E. coli fumarate reductase are incorporated into a proposed 
mechanism of Q reduction in photoreaction centers (7, 8), Glu-29, Ala-32, His-82, Trp-86 
of FrdC and His-80 ofFrdD are considered participants in a QB-type site, and FrdD phe-
57, Glu-59, and Ser-60 in an apolar QA-type site (6). According to the proposed structure 
of E. coli FrdC and FrdD, the QB-type site is located at the cytoplasmic side and the QA-
type site at periplasmic side. If this reasoning is applied to beef heart mitochondrial 
succinate-Q reductase, the Q-binding domain identified in QPsl (l)wouldbe the QB-type 
site and the domain in QPs3 would be the QA-type site. More detailed information on Q-
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. Figure 14. 3H radioactivity distribution on HPLC chromatograms of chymotrypsin-
. . 
.. . . 
digested, [3H]-azido-Q-labeled QJ>s2 (Panel A) and. [3H]-azido-Q-labeled QPs3 (Panel B). 
The reductive carboxym~thylated, succinylated, [3H]-azido-Q labeled QPs2/QPs3, l 
.. mg/ml, 3.6 x 104 cprn/mg, was digested with chymotrypsin, and 100-:µl aliquots of the 
digested solution were subjected to HPLC as described under "Experimental Procedures". 
100-µl aliquots were withdrawn from each tube for radioactivity determination. 
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Figure 15. Location of The Q-binding Site in QPs3 of Bovine Succinate -Q Reductase 
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Possible relationship between 0Ps2 and 0Ps3 
During the course of immunological studies of QPs3 we observed that antibodies 
against QPs3, the N-terminal, and the connecting peptides of QPs3 cross react with QPs2 
(see figures 7 and 11). This immunocross reaction of QPs2 and QPs3 is expected because 
the QPs3 sequence is contained in QPs2. This is evident from the following observations: 
(i) when a electrophoretically pure QPs2 preparation is subjected to protein sequencing, a 
major peptide with a partial N-terminal amino acid sequence of Serc:.Pro-Ser-His-His-Ser-
Gly-Ser-Lys-Ala- is obtained. The same sequence was obtained for QPs2 when the protein 
was obtained by two different methods, 1. electroeluted protein from gels, 2. 
electroblotted protein band on PVDF membrane. This sequence contains five amino acid 
residues from the C-terminus of the presequence and five amino acid residues from the N-
terminus of mature QPs3, suggesting that QPs2 is incompletely processed Qps3; (ii) when 
chymotrypsin digested QPs2 and QPs3 are subjected to HPLC separation, identical 
chromatograms are obtained (iii) when peptides with identical retention times, from the 
respective QPs2 and QPs3 HPLC chromatograms, are sequenced, identical sequences are 
obtained; (iv) the [3H]-azido-Q labeled peptide from QPs2 is identical to that from QPs3. 
(v) The antibody raised against recombinant QPs3 subunit crossreacted with QPs2 (Figure 
18). At present we do not know whether QPs2 is the same or a different gene product than 
QPs3 .. This requires further investigation. 
Chapter Summary 
Previous photoaffinity labeling studies of SQR using 3-azido-2-methyl-5-methoxy-
[3H]-6-decyl-1,4-benzoquinone ([3H]-azido-Q), identified QPs3 as one of the putative Q-
binding proteins in this reductase. An azido-Q-linked peptide with a retention time of 66 
min is obtained by high performance liquid chroatography of carboxymethylated and 
succinylated [3H]-azido-Q-labeled QPs3 purified from labeled SQR by a procedure 
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involving phenyl-sepharose 4B column chromatography, preparative SDS-PAGE, and 
acetone precipitation. The amino acid sequence of this peptide is NH2-L-N-P-C-S-A-M-D-
Y-COOH, corresponding to the residues #29-37. The quinone binding domain in the 
proposed model of QPs3 is probably located at the end of transmembrane helix I toward the 
C-side of the mitochondrial inner membrane. The finding that the Q-binding domains on 
QPsl and QPs3 are located on opposite sides of the membrane is consistent with a two Q-
binding site hypothesis formulated from inhibitor studies of this erizyme complex. 
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CHAPTER IV 
EXPRESSION AND PROPERTIES OF QPs3 OF BOVINE HEART 
SUCCINATE-Q REDUCTASE. 
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The availability of functionally active QPs3 is essential in order to better understand the 
structure-function relationship of QPs3 in SQR, especially on its role in Q-binding, heme ligation 
of cytochrome bs60, and succinate dehydrogenase docking. The failure of isolating QPs3 either 
from SQR or QPs coupled with the availability of the cDNA for QPs3 in our laboratory, has 
encouraged us to develop a method to over-express QPs3 in E. coli as a glutathione S-transferase 
fusion protein, using the pGEX expression vector system ( 1 ), which allows one-step affinty 
purification of the recombinant fusion protein with glutathione-agarose gel. In this chapter, I 
report the construction of a pGEX expression vector for QPs3, pGEX/QPs3, growth conditions 
for overexpression ofthe active soluble form ofGST-QPs3 fusion protein in E.coli, isolation and 
characterization of recombinant QPs3. 
Experimental Procedures 
Materials 
Restriction enzymes, T4 polynucleotide kinase, T4 DNA polymerase, T4 DNA 
ligase, were either obtained from Promega or from Life Technologies Inc. Plasmid 
preparation and fragment isolation kits were obtained from Qiagen. Nitrocellulose 
membranes were from Schleicher & Schuell. Bovine serum albumin, isopropyl-~,.D-
thiogalactopyranoside (IPTG), D-glucose, ampicillin, tetracycline, o-aminolevulunic acid, 
ferrous sulfate, gelatin, hemin chloride, sorbitol, betaine, glutathione, (reduced form), 
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glutathione agarose beads, thrombin, leupeptin, phenylmethylsulfonylfluoride (PMSF) and 
2,6-dichlorophenol indophenol (DCPIP) were from Sigma. Agarose, acrylamide, 
bisacrylamide, HRP color development reagent, protein A horseradish peroxidase 
conjugate and Bradford reagent were obtained from Biorad. LB agar, LB broth base, 
Select peptone 140 and Select yeast extract were from Life technologies Inc. Dodecyl 
maltoside was from Anatrace. Oligonucleotides were synthesized by the Recombinant 
DNA/ Protein Resource Facility at Oklahoma State University. 
Bacterial Strains and Plasmids 
E. coli strain INV aF' was used as host forPCR2.1 vector (Invitrogen); E. coli 
. JM109, or DH5a was used as host for pSelect (Promega) and pGEX2T (Pharmacia). 
DNA Manipulation and DNA Sequencing 
General molecular genetic techniques were performed according to procedures 
described in Sambrook et al (2). DNA sequencing was performed with an Applied 
Biosystems model 373 automatic DNA sequencer at the DNA/Protein Resource Facility at 
Oklahoma State University. 
Isolation of Recombinant GST-0Ps3 fusion protein 
400 ml of an overnight culture of E. coli JM109 I pGEX/QPs3 was used to 
inoculate 12 liters of SOC medium containing 440 mM sorbitol, and 2.5 mM betaine and 
60 mg/liter ampicillin. The culture was grown in a fermentor chamber with aeration until 
the OD660nm reached 0.9 (about 3.5 hours). The culture was cooled until it reached 25°C 
and IPTG was added to a final concentration of O .4 mM. Growth was continued until 3 .5 
hours post-induction and then harvested by centrifugation at 8,000 x g for 15 min. About 
48 g (wet weight) of cells were obtained and resuspended in 3 ml I g of PBS buffer (20 
mM Na/K phosphate pH 7.3, containing 150 mM NaCl). Cells were disrupted by 
sonication at O °C at 30 milliwatts for a total of 80 seconds: four 20-second pulses 
separated by 3 to 4 min intervals. During sonication PMSF and leupeptin were added to a 
final concentration of 1 mM, and 0.01 mg/ml respectively. Triton X-100 was added to the 
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broken cell suspension to final concentration of 1 % {w/v). The mixture was stirred on ice 
for 1 hour and centrifuged at 30,000 x g and the supernatant was mixed with an equal 
volume of glutathione agarose gel equilibrated with PBS. The mixture was stirred at 4 °C 
for 1 hour after which the gel was packed into a column and washed with the equilibrating 
buffer extensively at a flow rate of 0.8 ml/min .. The bound fusion protein was eluted with 
50 mM Tris-HCl pH 8.0, containing 5 mM reduced glutathione and 0.25 M sucrose. The 
OD2so of fractions were determined and the fractions containing the fusion protein were 
pooled and dialyzed against 50 mM Tris-HCl, pH 8.0, containing 0.25 M sucrose for at 
least 8 hours with 2 changes of buffer. The dialyzed sample was concentrated with a 
centriprep (Arn.icon), to a protein concentration of 5 mg/ml, mixed with glycerol to a final 
concentration of 10% and frozen at ~80 °Cuntil further use. QPs3·protein was released 
from GST-QPs3 by thrombin digestion (lµg/500µg) and isolated by gel filtration using a 
superose-12 column. 
Enzyme Preparations and General Biochemical Techniques 
QPs (3) was prepared as reported previously. Absorption spectra and eniyme 
assays were performed at room temperature in aShimadzu UV-2101PC. Protein content 
was determined by the Lowry method or Bradford assay using a kit from Biorad. The 
heme content was determined by pyridine hemochromagen spectra using a millimolar 
extinction coefficient of 34.6 for the absorbanceat 557nlll minus 600 nm (4). SDS-
. ' 
PAGE, was done according to Laemmli (5) or Schagger et al. (6) The EPR measurements 
were made with a Bruker ER-200D equipped with an Air Product Heli-Tran System. 
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Results And Discussion 
Construction of Expression Vector for QPs3 
Our previous success in overexpression of functionally active subunit IV of the R. 
sphaeroides cytochrome bq complex (7), the QPc-9.5 kDaofbovine QCR(8), and QPsl 
of bovine SQR in E. coli using the pGEX system (9), encouraged us to use the pGEX 
system to express QPs3 in E.coli. The expression vector for QPs3, pGEX/QPs3, was 
constructed by in-frame fusion of QPs3 gene into the glutathione S-transferase gene in 
pGEX-2T plasmid (Figure 16). Since BamHI and Eco RI sites are unique sites in the 
pGEX-2T vector and are missing in mature QPs3 cDNA, the in-frame fusion of the QPs3 
gene with the GST gene in pGEX-2T plasmid was achieved by generating a BamHI-EcoRI 
fragment encoding mature QPs3 and subsequently ligating it into the BamHI and EcoRI 
sites of the pGEX-2T plasmid. The 331 bp BamHl-EcoRl cDNA fragment encoding 
mature QPs3 was amplified from a bovine heart cDNA library by PCR using two synthetic 
primers, 5'GGATCCTCTGGTTCCAAG3' (the sense primer) and 
5'GAATTCTAAAAGGTCAGAGC3' (the antisense primer). This fragment was cloned 
into PCR2.1 vector and confinned by DNA sequencing before being subcloned into the ·. 
BamHl and EcoRl site of pGEX2T vector to generate pGEX/QPs3. E. coli transformants 
producing the GST-QPs3 fusion protein were identified by immunological screening of 
colonies with anti-peptide QPs3 antibodies (10). Both E.coli strains JM109 and DH5a 
were found to be suitable hosts for pGEX/QPs3. 
Production and Purification of Recombinant QPs3 
Production of recombinant GST-QPs3 fusion protein was IPTG concentration, 
induction growth time and induction growth medium dependent. The yield increased as the 
IPTG concentration and induction growth time were increased, reaching a maximum when 
cells were harvested 3 h after 0.4 mM IPTG growth induction (Figure 17). When IPTG 
Sit, Dktttol Mutag'"'"' with \ 
Primers and Ampicillin Repair Olig\ 
l'hrombln 
Barn HI & 
Eco RI 
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Figure 17. The Time Course of IPTG Induction of GST-QPs3 Expression in E. coli 
JM109. 
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A. SDS-PAGE,(12% acrylamide, laemmli's system) lane 1 is prestained 
SDS-PAGE standards. Lanes 2-6 represent an aliquot of whole cells at 0, 1, 
2, 3, and 4 hours after the addition of IPTG. 
B. Western blot of A. The proteins on A were electrophoretically transferred 
to nitrocellulose membrane. Monospecific polyclonal antibodies that were 
raised against QPs3 peptides were used as the primary antibody. Protein A-
horseradish peroxidase conjugate was used as a second antibody 
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concentration was increased to 1 rnM, no change in expression yield was observed When 
cells were grown for more than 5 h, the total yield decreased and degradative products 
increased as determined by western blotting using anti-QPs3 peptide antibodies. The yield 
of recombinant GST-QPs3 fusion .Protein could be increased in E. coli by using an 
induction growth medium containing magnesium. When LB or peptone,..p:hosphate 
enriched medium was used, production of GST-QPs3 fusion protein in E. coli accounted 
for less than 1 % of the total cellular protein. However, including 5 rnM magnesium in the 
enriched medium or using SOC medium increased the yield of GST-QPs3 fusion protein in 
E. coli to about 15% (Table IV). A.though the yield of fusion protei~ in E .. coli was 
slightly higher with enriched medium supplemented with magnesium, :the SOC medium 
was preferred because of lesser degradation products with the latter. 
E. coli is generally well known fol' rendering foreign proteins expressed in its cell 
as insoluble aggregates or inclusion bodies .. When the recomt>inant fusion protein was 
mostly synthesized as insoluble aggregates, its affinity to glutathione gel was reduced and 
our one step purification is limited .. Hence it is necessary to choose conditions for 
expression so that the fusion protein was soluble or detergent soluble and properly folded· 
to recognize the binding to the affinity gel. Although methods are available to convert the 
denatured inclusion body to soluble form, it is worthwhile to change growth conditions to 
make the cells to produce active soluble fusion protein. The increase in soluble yield by 
including betaine and sotbitol in the culture medium ~d growing the induced ceUs at 27 °C 
instead of 37 °Chas been reported for GST-QPc-9 .5 kDa fusion protein (8), GST-QPs 1 
(9) and DMAPP:AMP transferase (11). Although the reason for this increase is not 
. ,.,' . :. . 
known, it has been suggested (11) that increased internal concentratic:ms of compatable 
osmolytes, like betaine, cause a thermodynamically unfavourable "preferential hydration" 
which minimizes solvent-protein contact and stabilizes protein structures. When the growth 
Table IV. 
The Yield of Recombinant GST ~QPs3 Fusion Protein in The Soluble and Inclusion Body 
Fractions of E. coli JM109 / pGEX-QPs3 Cells in Different Growth.Media at Room . 
Temperature 
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Growth Medium % Total Fusion % Soluble Fraction % Inclusion body 
Protein* 
soc 7.5 1.0 6.5 
SOC + betaine + 9.2 3.5 5.5 
sorbitol 
Enriched Medium 0.3 · 0;3 -
Enriched+.· 7.5 1.5 6.0 
Mamesium 
Enriched+ 15 5.5 9.8 
Magnesium+ 
Sorbitol + Betaine '. 
* The % refers to the intensity of the 37 k Da fusion protein band as compared with the 
total intensities of cellular protein bands on SDS-PAGE 
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medium was supplemented with 0.44 M sorbitol and 2.5 mM betaine there was a three fold 
increase in the yield from the soluble fraction (12-13% of total GST-QPs3 without betaine-
sorbitol to 34-36%). The IPTGinduction growth in SOC medium containing 2.5 mM 
. . 
betaine and 440 mM sorbitol at 25 °C for 3.5 hours was found to be optimal for the 
production of soluble recombinant GST-QPs3 fusion protein. 
The SOS-PAGE analysis of fusion protein obtained from the affinity column 
showed the 37 kDa fusion protein as the major band (Figure 18 panel A lane 3). When the 
fusion protein was treated with thrombin at a ratio of 1:500 w/w at 25 °C in theptesenceof 
0.01 % lauryl maltoside most of QPs3 i~ the fusion protein could be cleaved in about one. 
hour. The recombinant QPs3 thus obtained was dispers.ed in detergent with an estimated 
. . 
molecular weight of over 500 kDa and could be recovered from the digestion mixture in the 
. . . 
void volume of superose 12 column (Pharmacia)i When the thrombin released QPs3 was 
subjected to SOS-PAGE, it was detected as a single band corresponding to the fifth subunit 
in succinate-Q reductase (Figure 18, panel A, lane 5). The protocol to obtain recombinant 
QPs3 is detailed in Scheme IV. 
Quinone-binding Properties ofRecombinant QPs3 .. 
Since QPs3 has been identified as one of the Q-binding proteins in SQR (8) it is of 
interest to see whether or not recombinant QPs3 can bind Q. It was reported that addition 
of QoC10Br to recombinant QPc.:.9.5 kDa subunit (Q-binding sµbunit of QCR) causes a 
• • C ' • '•, ' 
spectral blue s~ft. The. spectral shift was found to be protein concentr~t:ion dependent and 
reached a saturation concentration (8, 12). · When QoCtoBr in 95% ethanol was added iri 
small increments to recombinant QPs3 in a 20 mM sodium phosphate.buffer containing 
. . . ! 
. . 
0.25 M sucrose, 150 rnM NaCl, 2.5 mM CaCl2, 10% ethanol 0;01 % lauryl maltoside and 
5% glycerol, a spectral blue shift of Q was observed (Figure 19). Titration of recombinant 
QPs3 with Q showed a saturation point at around l.1 moles of Q per mole protein 
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Figure 18. Characterization of antiGST-QPs3 antibodies and identity of recombinant QPs3 . 
A: SDS-PAGE. Lane 1 represents prestained molecular weight markers; lane 2 
Bovine heart mitochondrial succinate-ubiquinone reductase; lane 3 GST-QPs3 from 
the affinity column; lane 4, GST-QPs3 after thrombin digestion; lane 5 purified 
recombinant QPs3 . The high resolution SDS-PAGE system of Schagger et al was 
used. The proteins in A were electrophoretically transfered to nitrocellulose 
membrane, and reacted against anti-connecting peptide antibodies in Panel Band anti-
GST-QPs3 antibodies in Panel C. Protein A horseradish peroxidase conjugate was 
used as second antibody. 
Scheme IV 
The protocol for isolation of the Recombinant QPs3 protein from E. coli 
JM109/pGEX-QPs3 
Overnight grown JM109/pGEX-QPs3 cells l .. 
S0Cmedimn containing2.5 mM betaine and 440 .mM sorbitol 
. ·. ·1 •. . 
Growth at 37°C until OD660 of culture is 0.9 
l 
Cooling of culture to 25 °C and IPTG induction 
. . l . . 
Harvest cells after 3.5 hrs growthat 25 °C and suspend in PBS buffer 
l 
Breaking of the cells, 1 % Triton solubilization, and centrifugation at 5000 xg 
l 
Crude extract is gently shaken with GSH-agarose beads at 4 °C 
l 
The bound fusior protein is el1ted with 5 rnM glutathione buff er 
GST-QPs3 
l 
Thrombin Digestion . . •. l .. 
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Figure 19. Effect of recombinant QPs3 on the absorption maxima of Q. One ml aliquots of 20 
mM sodium phosphate buffer pH 7.3 containing 150 mM NaCl, 2.5 mMCaC12 10% 
ethanol and 0.01 % lauryl maltoside was added to 50 µ150 mM Tris-HCl pH 8;0 
buffer containing ofGST(o), orrecombinantwild typeQPs3 C•). The final protein 
concentration was 300 µg/ml. Each sample was prepared in duplicate and Q0C1oBr in 
95% alcohol was added in 1 µl increnients to one sample cuvette to obtain the indicated 
concentrations. The same amouµt of alcohol alone was added to the reference cuvette. 
After each addition the sample was incubated for 5 min and a difference spectra 
between the Q0C1oBr-added and alcohol-added samples was recorded from 320 nm to 
250 nm. 
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Restoration of Cytochrome b560 to Recombinant QPs3 by Heroin-Chloride 
The QPs fraction of mitochondrial SQR is associated with a cytochrome bs6o, that 
is found in substoichiometric ratio with respect to FAD. The cytochrome bs60 is not 
reducible by succinate and shows altered spectral.characteristics and CO sensitivity in the 
presence and absence of SDH (to recall see page 15 of this thesis). Previous near infra red 
MCD (magnetic circular dichroism) spectroscopic studies of SQR and isolated 
mitochondrial QPs indicate a bis-histidine ligand for cytochrome b560 (13). In general, 
mitochondrial QPsl is believed to be the cytochrome b560 of SQR. This has been recently 
substantiated by in vitro heme reconstitution of recombinant GST-QPs I to form 
cytochrome bs6o (12). However in the E.coli SQR, cytochrome b556 is ligated by 
histidine 84 fromSDHC and and histidine 71 from SDHD subunits (14). In this case both 
subunits are essential for heme ligation. Although recombinant QPsl can form cytochrome 
b560, QPs2 and/or QPs3 could also have putative histidine ligands for cytochrome b560 
To test whether QPs3 has putative histidine ligands we attempted in vitro heme 
reconstitution of recombinant QPs3. 
Purified recombinant QPs3 did not contain any cytochrome bs6o. The addition of 
aminolevulunic acid, the committed precursor for heme synthesis, to the IPTG~induced 
E.coli cultures did not result in any increase in the cytochrome bs6o content of QPs3. 
Since GST-QPs3 was in a soluble form unlike the rQPs3 which is in a detergent dispersed 
form, it was more suitable for our heme reconstitution experiments. When hemin chloride 
was added to GST-QPs3, the maximum absorption peak (Soret band) of the oxidized form 
of heme shifted from 398 nm to 411 nm with increasing absorbance. The spectral shift 
was reached after one hour incubation at room temperature. At the end of the incubation 
time when the sample was reduced with dithionite, a characteristic cytochrome b560 
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Figure 20. Restoration of cytochrome b560 inheme reconstituted recombinant GST-QPs3. 
3 µl of 6 mM hemin chloride in DMSO was added to 1.5 mg of GST-QPs3 
(Panel A) and 1.5 mg of GST (Panel B) in 1 ml, in Tris-HCl pH 8.0 buffer, 
containing 0.25 M sucrose. The oxidized (-) and the dithionite reduced (---) 
spectra were recorded at room temperature. The inset represents the difference 
spectrum of dithionite-reduced versus the oxidized.form in the·a and~ regions. 
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. nm was generated (Figure 20 panel A). These spectral characteristics are identical to those 
of cytochrome b560 of a reconstitutively active QPs preparation. Whe11.GST protein 
. . 
isolated from E. coli cells JM109/pGEX2T was incubated with hem.in chloride in a similar 
manner as GST-QPs3, no cytochrome bs6o spectrum was generated (Figure 20 panel B). 
This indicates that the two heme ligands are solely provided by QPs3. 
EPR Characterization of GST-0Ps3 Protein after Heme Reconstitution 
Figure 21 shows the EPR characteristics of mitochondrial QPs, GST with hemin 
chloride, and heme reconstituted GST-QPs3 protein before and after thrombin treatment. 
. . 
Reconstituted cytochrome b560 in GST-QPs3 sh6ws an EPR peak at g=2.91 corresponding 
to one of the two EPR signals (g=2.91 and g::::::3.07) observed for cytochrome bs6o in 
isolated QPs. The g=2.91 peak was regarded as a reconstitutively inactive peak since only 
the g=3.07 peak disappears upon the reconstitution of QPs with SDH to form SQR. 
However this second peak is still due to a bis histidyl ligation of heme according to 
previously reported studies in Desulfovibrio vulgaris (15, 16). In this species the 
cytochrome c3 has 4 hemes (g=3.16, 2.95,2.95; and 2.71) all of which have histidines as 
the fifth and sixth ligands. The ligands have been identified by crystallographic studies. 
The g=2.95 signal is attributed to the imidazoles being almost coplanar lying close to a 
methine-methine vector (15). 
The restoration of cytochrome h560 was heme concentration dependent (Figure 22). 
When 0.4 mg of GST"'QPs3 was incubated with different amounts·ofhemin chloride 
corresponding to molar ratios ranging from Oto 1~5 ofheme to protein, the·peak height at 
560 nm increased up to a ratio of 0. 7 5 mole of heme to 1 mole protein. On the addition of 
more heme there was a presenc~ of broad shoulder between 570 and 580 indicating the 
presence of free heme. Beyond the molar ratio of 0. 7 5 heme per mole. protein the increase 
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Figure 21. EPR spectra of heme reconstituted Wild type GST-QPs3 protein before and 
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after thrombin treatment:- Trace A- mitochondrial QPs, trace B~GST-QPs3 
with hemin Chloride, trace C- GST-QPs3 with hemin chloride and thrombin. 
15 µl ofhemin chloride in DMSO was added to 0.6 ml of Tris-HCl buffer 
containing the protein samples (10 mg I ml ) and incubated at room temperature 
for 1 hr prior to EPR measurement. Thrombin was added at 0.01 unit/µg of 
protein. The EPR settings were: modulation frequency, 100 KHz; modulation 
amplitude, 20 G; time constant, 0.5s; microwave frequency, 9.42 GHz; 
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Figure 22. Effect of heme concentration on the reconstitution. of cytochrome b560 
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One ml aliquots of purified GST-QPs3 fusion protein, 0.85 mg/ml, in PBS 
buffer were added to 3 µl of DMSO containing indicated concentrations of 
hemin chloride, incubated at room temperature for one hour, before . . 
determining the difference spectra between the oxidized and the reduced 
forms with (x) and without ( o) thrombin digestion. 
When heme reconstituted, thrombin-treated GST-QPs3 was passed through a 
superose 12 column, and each fraction was analyzed for its absorption spectra, SDS-
PAGE, and Western blotting, cytochrome b560 was found only in the QPs3 containing 
fractions. No cytochrome was detected in the GST fractions. These results further 
confirm the fact that QPs3 contains putative heme Hgartds of cytochrome h560. The 
82 
. identification .of ligands of cytochrome h560 by site-directed mutagenesis is described in the 
succeeding Chapter. 
·.··Chapter Summary 
QPs3 of bovine SQR was over-expressed. in E. coli as a ghitathione S-transferase 
(GST) fusion protein using the constructed expression vector, pGEX2T/QPsJ. The yield 
of recombinant fusion protein was growth conditions dependent The maximum yield was 
obtained from cells harve,sted 3.5 hours post-induction growth at 25 °C.on SOC medium 
. . 
containing 440 mM sorbitol, 2,5. niM betaine; QPs3 was rele~s~d from the fusion protein 
. . 
by proteolytic cleavage with thrombin. Isolated recombinant QPs3 showed one protein 
band in SDS-PAGE corresponding to the fifth subunit of SQR. Recombinant QPs3 
showed Q-binding that is specific since its titration against quinone resulted in a spectral 
blue shift that reached saturation. Recombinant QPs3 contained no cytochrome bs6o. 
However, addition of hemin chloride restored the spectral characteristics of cytochrome 
bs6o. Reconstituted cytochrome bs6o showe~ a epr signal at g=2.91 which corresponded 
to one of the epr signals of cytochrome bs6o in a recbnstitutively active QPs preparation. · 
The epr and spectral prop~rties were not affected by the thrombin treatment suggesting that 
both the ligands of the cytochrome h560, probably histidines, are provided by QPs3. 
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CHAPTER V 
IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR Q-
BINDING AND HEME LIGATION OF QPs3 OF BOVINE HEART 
SUCCINATE-Q REDUCTASE 
The availability of a functionally active recombinant QPs3 ( chapter IV) provides us 
the opportunity to undertake structure~function studies of this subunit. The Q-binding site 
of this subunit was identified as the stretch of amino acids from leucine 29 to tyrosine 37 
by photoaffinity labeling and isolation and sequencing of an azido-Q linked QPs3 peptide 
( 1 ). Heme reconstitution of GST-QPs3 showed that heme binding was specific and the 
cytochrome spectrum generated was due to ligands provided by QPs3. In this chapter I 
report the identification of the amino acid residues responsible for Q-binding and heme 
ligation by site directed mutagenesis and in vitro Q-binding and heme reconstitution assays 
of the mutated QPs3 protein. 
Experimental Procedures 
Materials 
Restriction enzymes, T4 polynucleotide kinase, T4 DNA p()lymerase, T4 DNA 
ligase, were either obtained from Promega or from Life Technologies Inc. Plasmid 
preparation and fragment isolation kits were obtained from Qiagen. Nitrocellulose 
membranes were from Schleicher & Schuell. Bovine serum albumin, isopropyl-~-D-
thiogalactopyranoside (IPTG), D-glucose, ampicillin, tetracycline, 8-aminolevulunic acid, 
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ferrous sulfate, gelatin, hemin chloride, sorbitol, betaine, glutathione, (reduced form), 
glutathione agarose beads, thrombin, leupeptin, phenylmethylsulfonylfluoride (PMSF) and . 
2,6-dichlorophenol indophenol {DCPIP) were from Sigma. Agarose, acrylamide, 
bisacrylamide, HRP color developrilentreagen:t, protein A horseradish peroxidase 
conjugate and Bradford reagent were obtained from Bforad. LB agar, LB broth base, 
Select peptone 140 and Select yeast extract were from Life Technologies Inc .. Dodecyl · 
maltoside was from Anatrace. Oligonucleotides were synthesiz~d by the DNN Protein 
Resource Facility at Oklahoma State University: 
Bacterial Strains and Plasmids 
E.coli strain INVcxF' was used as hostfor PCR2.l vector(lnv1trogen); E.coli 
JM109, or DH5a was used as host for pSelect (Promega) and pGEX2T (Pharmacia). 
. . ~ 
DNA Manipulation and DNA Sequencing 
· General molecular genetic techniques were perforrped according to procedures· 
described in Sambrook et al (2). DNA sequencing wa,s performed with an Applied 
Biosystems model 373 automatic DNA sequencer at the DNNProt~in Resource Facility at 
Oklahomcl State University.· 
Construction of Mutants and Expression of Mutated 0Ps3 as GST Fusion Proteins 
·inE. coli 
A 342 base pair EcoRI fragment was excised from PCR2.1/QPs3 plasmid and 
. . 
· cloned into the EcoRI site ()f pSELECT-1. ( tetracycline resistant and arnpicillin sensitive) 
. vector. The. single-stranded pSELECT/QPs3 was _used as the template in the mutagenesis 
reactions. The mutagenic primers used ate as follows: 
H9N- 5'GCATCTCTC.8,ACTGGACTGGT; H9Y-• 5'GCATCTCTCTACTGGACTGGT 
H9D- 5'GCATCTCTCQACTGGACTGGT; H46N- 5'CTCACTCTT.8,ACAGTCACTGG 
fi46Y- 5'CTCACTCTTTACAGTCACTGG; H46D- 5'CTCACTCTTQACAGTCACTGG 
H48N- 5'CTTCACAGT.8,ACTGGGGCATT; H48Y- 5'CTTCACAGTTACTGGGGCATT 
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H48D- 5'CTTCACAGT~ACTGGGGCATT; H60N- 5'GACTATGTT8,A.TGGAGATGCA 
H60Y- 5'GACTATGTTTATGGAGATGCA; H60D- 5'GACTATGTTQ.ATGGAGATGCA 
H89N- 5'TTCAACTAT8,A.TGACGTGGGC; H89Y- 5'TTCAACTATTATGACGTGGGC 
H89D- 5'TTCAACTATQ.ATGACGTGGGC; S33A- 5'AATCCGTGTGCTGCGATGGAC; 
D36A- 5'CTGCGATGGCCTACTCTC; Y37A- 5'CGATGGACGCCTCTCTGGC 
Each of these oligos was used in combination with an ampicillin repair oligo and annealed to the 
single stranded pSELECT/QPs3. This mutagenesis procedure produced greater than 50% mutants. 
The double mutant H46,60 N was constructed by annealing the H46N oligonucleotide primer to · 
single stranded H60N-pSELECT-QPs3. The presence of mutation was confirmed by DNA 
sequencing both in pSELECT and pGEX vectors carrying the mutated QPs3 gene. The 
transformants expressing the fusion protein were identified by immunological screening of 
bacterial colonies with antibodies raised against QPs3 connecting peptide (1). Isolation of 
recombinant mutant GST-QPs3 fusion protein was done in a similar manner as the wild type. 
The heme content was determined by pyridine hemochromagen spectra using a 
millimolar extinction coefficient of 34.6for the absorbance at 557 nm minus 600 nm (3). 
SOS-PAGE, was done according to Laemmli ( 4) or Schagger et al. (5) The EPR 
measurements were made with a Bruker ER-2000 equipped with an Air Product Heli-Tran 
System. 
Results And Discussion 
Identification of Amino Acid Residues Involved in Q-binding of QPs3 
The photoaffinity labeling techniques used to locate the Q-binding sites did not 
allow the identification of a specific Q-binding residue due to the longer life and nonspecific 
nature of the nitrene radical. The availability of a functionally active recombinant QPs3 
provides us the opportunity to identify the putative Q-binding residues by a molecular 
genetics approach .. 
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From crystallographic studies of the reaction center (6) it is known that two types of 
residues are important for Q-binding and Q-mediated electron transfer. The first type is of 
those amino acids that can form hydrogen bonds with the carbonyl oxygen of the 
benzoquinone ring. The second type is aromatic residues whose conjugated ring can 
stabilize the 1,4 benzoquinone ring by 1Mt interaction. The Q-binding domain of QPs3 
shows serine33, and aspartate36 as candidates for hydrogen bonding, and tyrosine37 as a 
candidate for aromatic interaction. Each of these residues were individually altered to 
alanine and the mutant tecombinarit QPs3 isolated and analyzed for the Q-bindingability. 
D36A mutant showed similar Q-binding (Figure 23) as the wild type suggesting that this 
residue may not be important for Q-binding; howeverS33A and Y36A did not show the 
spectral blue shift and these two residues are probably involved in Q-binding in bovine 
. . 
SQR. Definitive assignment has to await the three-dimensional structure of this reductase. 
Identification of Heme Ligands of Reconstituted Cytochrome b:ifill of Recombinant 0Ps3 
QPs3 has five histidine residues at positions 9, 46, 48,:6Q and 89 in its amino acid 
sequence. In order to identify the histidine residues ligating the heme we altered each ofthe 
histidine residues to asparagine, tyrosine and aspartate, by.sit~ directed mutageilesis and 
assayed the mutant QPs3 for their ability to reconstitute cytochrome bs6o with hemin 
chloride. We failed to obtain expressed H46:b, H48D, H60D, H60:Y H89D and H89Y 
mutant QPs3 proteins since they could be expressed only as inclusion bodies. All the other 
nine mutants (H9D, H9~,H9Y, H46N, H46;, H48N, H48Y,H60N, andH89N) were 
isolated in the same manner as the wild type GST-QPs3. · The expression level and yield of 
H9Y, H46N, H48Y were higher than the wild type, but the elution of H48Y required 10 
. mM glutathione instead of 5 mM glutathione and pH of the eluting buffer at 8.5 rather than 
8.0. A final yield ranging from 4 to 5mg fusion protein per liter culture was obtained in 
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Figure 23. Effect of mutant recombinant QPs3 on the absorption maxima of Q. One ml aliquots of 
20 rnM sodium phosphate buffer pH 7.3 containing 150 mM NaCl, 2.5 rnMCaC12 10% 
ethanol and 0.01 % lauryl maltoside was added to 50 µ150 rnM Tris-HCl pH 8.0 
buffer containing the respective mutant recombinant QPs3:- S33A(A), D36A (D), and 
Y37A { +). The final protei,n concentration was 3QO µg/rnl. :Each sample was prepared 
in duplicate and QiC1J3r in 95% alcohol was added in 1 µl increments to one sample 
cuvette to obtain the indicated concentrations. The same amount of alcohol alone was 
added to the reference cuvette. · After each addition. the sample was incubated for 5 min 
and a difference spectra between the Q0C1J3r-added and alcohol-added samples was 
recorded from 320 nm to 250 nm. 
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Heme. reconstitution of QPs3 mutant proteins 
Hemin chloride dissolved in DMSO was added to each of the isolated mutant QPs3 
at the ratio of 0. 7 5 heme to protein and the spectral properties were analyzed after thrombin 
treatment. The heme added H9D, H9N, H9Y, H48N, and H89N mutant proteins showed 
spectral characteristics essentially equivalent to the wild type (Figure 24) indicating that 
these histidines are not involved in heme ligation. However the spectra of H46Y and 
. . . . . . . 
H60N showed slight changes in the soret region of the spectrum; the absorption maxima 
shifted from 424 nm to 438 nm (Figure 24 ).' In the case of H46N mutant there was no 
restoration of cytochrome h560 in the heme added samples. When a double mutant 
. : . . . . 
H46,60N in which both the histidines at position 46 and 60 of the polypeptide were 
replaced by asparagine, was reconstituted with hemin chloride, the alpha peak of the 
dithionite-reduced minus oxidized spectrum was broadened and looked similar to heme 
added GST suggesting that both H46 and H60 of QPs3 are involved in the ligation of 
heme. 
EPR Characterization of Mutant GST-QPs3 Proteins after Heme Reconstitution 
The mutants H9D, H9N, H9Y, H89Nshowed epr spectra comparable to the wild 
type (Figure 25). This further confirms that these residues are not essential for heme 
ligation. The mutants H46N, H46Y, H60N and H46,60N did not produce epr signal at 
g=2.9land this denotes that the cytochrome bs6owas not forme~ in .this mutant and H46 
and H60 provide the ligands to heme in cytochrome bs6o. 
H46 is identified as a conserve.ct residue ainong all the analogous QPs3 membrane 
anchor proteins and is replaced by tyrosine residue in yeast SDH4 subunit; a cytochrome 
bs6o has not so far been characterized in yeast SQR (7). This residue also corresponds to 
histidine 71 of E.coli SDHD which has been recently identified as ligand to cytochrome 
bss6 in E. coli SQR (8). On the other hand H60 is not a highly conserved residue among 
analogous QPs3 subunits 
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Figure 24. Dithionite-reduced minus oxidized spectra of QPs3 Wild Type and Mutant 
proteins The Panels are represented as follows: (i) Wild type, (ii) H9D, (iii) 
H9N, (iv) H9Y (v) H46N (vi) H46Y (vii) H48N (viii) H48Y (ix) H60N (x) 
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Figure 25. EPR spectra of heme reconstituted Wild type and mutant GST-QPs3 proteins 
after thrombin treatment. 15 µl of hemin chloride in DMSO was added to 0.6 ml 
of Tris-HCI buffer containingthe respective protein samples (10 mg I ml) and 
incubated at room temperature for 1. hrprior to EPR measurement: Thrombin 
was added at 0.01 unit/µg of protein. The EPR settings were: modulation 
frequency, 100 KHz; modulation amplitude, 20 G; time constant, 0.5 s; 
microwave frequency, 9.42 GHz; microwave power, 20 milliwatts; scan rate, 
200 s; temperature 10 k. 
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From the in vitro heme reconstitution studies of recombinant QPsl and QPs3 
subunits, it is evident that both can individually ligate heme to form cytochrome bs6o. It is 
possible that in the isolated SQR or QPs, both QPsl and QPs3 could ligate their own heme. 
If there could be two hemes in SQR, each ligated by QPsl and QPs3 then the cytochrome 
h560 content in isolated SQR should not be substoichiometric to flavin. 
In vitro reconstitution experiments using isolated SDH with either or both 
recombinant QPs subunits did not yield a TTF A sensitive SQR. The inability of obtaining 
a reconstitutively active fraction could be because QPs 1 and QPsJ subunits were purified 
from parallel sources. In order to improve the interaction between the two subunits both 
subnits can be coexpressed and the recombinant QPs can be tested for reconstitution with 
SDH. Alternatively the failure to obtainSQR activity could be due to the lacking of QPs2. 
Work in our laboratory is being directed toward knowing the identity of QPs2. 
Chapter Summary 
By a site-directed mutagenesis approach, histidines at position 46 and 60 of QPs3 
are identified to be responsible for heme ligation of cytochrome b of recombinant QPs3. 
Two residues, serine33 and tyrosine37 are identified to be crucial for Q-binding, since, 
when these amino acids weremutated to alanine the Q~bindingproperties of the 
recombinant QPs3 were altered from that of the wild type. 
References 
1. Shenoy, S. K. Yu, L., and Yu, C. A. (1997), J. Biol. Chem., 272, 17867-17872. 
2. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A laboratory 
Manual, Cold Spring Harbor Press, NY. 
3. Paul, K. G., Theorell, H., and Akesson, A., (1955) Acta. Chem. Scand., 7 1284-
1287. 
4. Laemmli, U. K. (1970) Nature, 227, 680-685. 
5. Schagger, H., Link, T. A., Engel, W. D., and vonJagow, G. (1986) Methods 
Enzymol., 126, 224-237. 
93 
6. Stowell, . H., McPhiHips, T. M., Rees, D. C., Soltis, S. M., Abresch, E., and Feher, 
G., (1997) Science, 276, 812-816. 
7. Rose, C. T., Cecchini, G. Nakamura, K., Kita, K., and Gennis, R. B. (1997), 
Biochemistry, 37, 4148-4159. 







SUDHA K. SHENOY . 
Candidate for the Degree of 
Doctor of Philosophy 
STRUCTURE-FUNCTION STUDIES OF QPs3. OF BOVINE 
HEART MITOCHONDRIAL SUCCINATE-Q REDUCTASE 
Biochemistry and Molecular Biology 
Born in India On May fifth J 962, the daughter of Tara Karnath and 
Gopalakrishna Karnath 
Graduated from Adarsh Vidyalaya Matriculation School, Madras, 
India in May 1978; received Bachelor's degree in Zoology from the 
University of Madras in May 1982; received Master's degree in 
Zoology from the University of Madras in May 1986. Completed 
the requirements for the Ph.D. degree in the field of Biochemistry 
and Molecular Biology at Oklahoma State University in December, 
1998. 
Abstracts Presented atMeetings: 
Publications: 
Cloning and sequencing of mitochondrial succinate'."Q reductase 
(l996)The FASEB Journal, 10, A1492; Expression and properties 
of QPs3 of mitochondrial succinate-Q reductase ( 1997) Biophysical 
Journal, 72, A319; Reactivation, cloning, and expression of Core 
proteins of mitochondrial bcl (1997) TheFASEB Journal, 11, 
A1280; Cloning and functional expression of Core proteins of bovine 
heart mitochondrial bcl complex (1998) Biophysical Journal 
' . 
Shenoy S. K., Yu, L. andYu, C. A. (1997) Smallest membrane 
anchor subunitQPs3 of bovine heart succinate-ubiquinone 
reductase: Cloning, sequencing, topology and Q-binding 1. Biol. 
Chem., 272, 17867-17872; Chen,Yi-R., Shenoy, S. K., Yu, C. 
A., and Yu, L. (1995) Identification of amino acid residues involved 
in structural and ubiquinone-binding functions of subunit IV of the 
cytochrome bc1 complex from R.sphaeroides., J. Biol. Chem., 270, 
11496-11501. 
Professional Membership: 
American Association for the Advancement of Science; 
Oklahoma Academy of Science. 
